2014 Annual Meeting | Poster Session 7

Date Thursday 05/01/14

Time 03:00 PM - 06:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging, Dementia, and Behavioral Neurology, Cerebrovascular Disease and Interventional Neurology, Child Neurology and Developmental Neurology, Epilepsy/Clinical Neurophysiology (EEG), General Neurology, Headache, Movement Disorders, Multiple Sclerosis, Neuromuscular and Clinical Neurophysiology (EMG), Neuro-oncology, Pain

CME Available No CME available

Event Timeline
03:00 PM - 06:30 PM	Abstract	001 - Deletion of Sarm1 gene protects against paclitaxel-induced peripheral neuropathy Ahmet Hoke, MD, PhD, FAAN
03:00 PM - 06:30 PM	Abstract	002 - Frequency and Time to Relapse after Discontinuing 6-month Therapy with Intravenous Immunoglobulin or Methylprednisolone in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Eduardo Nobile-Orazio, MD, PhD, FAAN
03:00 PM - 06:30 PM	Abstract	003 - Sudoscan as a Diagnostic Tool for Diabetic and Idiopathic Peripheral Neuropathy A. Gordon Smith, MD, FAAN
03:00 PM - 06:30 PM	Abstract	004 - Defective muscle mitochondrial biogenesis in spinal muscular atrophy.
03:00 PM - 06:30 PM	Abstract	005 - Genetic epidemiology of C9ORF72 in ALS: a national study in Italy
03:00 PM - 06:30 PM	Abstract	006 - Increased Cerebral Oxidative Stress In Amyotrophic Lateral Sclerosis: A 62Cu-ATSM PET Study Masamichi Ikawa
03:00 PM - 06:30 PM	Abstract	007 - The diagnostic value of diffusion tensor MRI metrics in relation to the MND phenotype heterogeneity
03:00 PM - 06:30 PM	Abstract	008 - Muscular Dystrophy Association U.S. Neuromuscular Disease Registry - Preliminary Findings
03:00 PM - 06:30 PM	Abstract	009 - The Course and Outcome of Pregnancy in Women with Nondystrophic Myotonias Yuliya Snyder, MD
03:00 PM - 06:30 PM	Abstract	011 - Differential Sensitivity of Oligodendrocyte Precursor Cells and Microglia to Methotrexate in Grey Versus White Matter Lauren Wood
03:00 PM - 06:30 PM	Abstract	012 - Functional Expression of K2P Potassium Channels in Tumor Infiltrating Lymphocytes of Malignant Glioma
03:00 PM - 06:30 PM	Abstract	013 - Polyneuropathy in Multiple Myeloma Patients Correlate with the Presence of Autoantibodies
03:00 PM - 06:30 PM	Abstract	014 - Development of a Mouse Model of Leptomeningeal Metastasis Adrienne Boire, MD, PhD, FAAN
03:00 PM - 06:30 PM	Abstract	016 - Paraneoplastic Neurological Syndromes: A Single Institution 10-Year Case Series Amy Chan, MD
03:00 PM - 06:30 PM	Abstract	017 - Delayed Diagnosis of Brachial Plexus Neurolymphomatosis in Post-transplant Patient with Diffuse Large B-cell Lymphoma Milena Stosic, MD
03:00 PM - 06:30 PM	Abstract	018 - Non-Richter's Transformation CLL in the CNS: A Case Series Varoon R. Thavapalan, MD
03:00 PM - 06:30 PM	Abstract	019 - Photodynamic Therapy (PDT) Of Brain Tumors Venu Parachuri, MD
03:00 PM - 06:30 PM	Abstract	021 - Babinski or Withdrawal? A New Way to Decide Sayyed Sohrab, MD
03:00 PM - 06:30 PM	Abstract	022 - Absent Inferior Vena Cava with Resulting Venous Congestion Causing Intermittent Cauda Equina Dysfunction Carrie K. Grouse, MD, FAAN
03:00 PM - 06:30 PM	Abstract	023 - Rare presentation of Eagle's Syndrome as Bell's Palsy Nancy D. Rosales, MD
03:00 PM - 06:30 PM	Abstract	024 - When the Typical Becomes Atypical: Anti-Ri Antibody Associated Paraneoplastic Syndrome WITHOUT Opsoclonus-Myoclonus Yadira Velazquez-Rodriguez, MD
03:00 PM - 06:30 PM	Abstract	025 - Diagnostic Confusion About a Confused Patient: A Case Of Delayed Post-Anoxic Leukoencephalopathy Syndrome Tammam Dayyoub, MD
03:00 PM - 06:30 PM	Abstract	026 - Nutritional Intake and Iron Bioavailability in Adolescents with Postural Tachycardia Syndrome Imad T. Jarjour, MD, FAAN
03:00 PM - 06:30 PM	Abstract	029 - Refractory IgG4-Related Intracranial Hypertrophic Pachymeningitis Bing Liao, MD
03:00 PM - 06:30 PM	Abstract	030 - Detecting Malingering: the Honest Palm Sign
03:00 PM - 06:30 PM	Abstract	031 - Case Report of Weston Hurst Syndrome Rick Magun, MD
03:00 PM - 06:30 PM	Abstract	032 - A case of PML after initiation of brentuximab vedotin for CD30 positive cutaneous T cell lymphoma Judy Jia, MD
03:00 PM - 06:30 PM	Abstract	033 - Electroencephalographic and Positron Emission Tomography Correlates in Anti-N-methyl-D-aspartate Receptor Encephalitis David R. Benavides, MD, PhD, FAAN
03:00 PM - 06:30 PM	Abstract	034 - Extra-motor symptoms in Amyotrophic Lateral Sclerosis. Analysis of 112 patients Hector R. Martinez, MD
03:00 PM - 06:30 PM	Abstract	035 - Hyperammonemic Encephalopathy in Late-Onset Ornithine Transcarbamylase (OTC) Deficiency Unmasked By Acetaminophen Overuse Heeral Mehta, MD
03:00 PM - 06:30 PM	Abstract	036 - Picture This! A Meta-Analysis Comparing Affective Salience of Words vs. Images Eithan Kotkowski, MD, PhD
03:00 PM - 06:30 PM	Abstract	037 - The Belgian Neuromuscular Disease Registry, Results of the 2012 Data Anna Roy
03:00 PM - 06:30 PM	Abstract	038 - Abnormal Near Field Potentials of Brainstem Origin in Parkinson's Disease (PD) Fidias E. Leon-Sarmiento
03:00 PM - 06:30 PM	Abstract	039 - CXCL10, CCL5 and IL-6 in cerebrospinal fluid of neuropsychologically unaffected patients correlate with neurofilament H Simon Faissner
03:00 PM - 06:30 PM	Abstract	040 - Prevalence and Predictors of Suicidal Ideation in Epilepsy and Multiple Sclerosis
03:00 PM - 06:30 PM	Abstract	041 - How Thin Can a Deep Brain Stimulation Lead Be?
03:00 PM - 06:30 PM	Abstract	042 - Wearable sensors for quantifying deep brain stimulation washout effects on gait in Parkinson's disease
03:00 PM - 06:30 PM	Abstract	043 - How Optogenetics Can Help Improve Deep Brain Stimulation for the Motor Symptoms of Parkinson's Disease
03:00 PM - 06:30 PM	Abstract	044 - Neuronal Oscillation Patterns In The Subthalamic Nucleus In Parkinsonia Patients With Off Dystonia Ping Zhuang, PhD
03:00 PM - 06:30 PM	Abstract	045 - Deep Brain Stimulation (DBS) and Oropharyngeal Dysfunction in Parkinson's Disease (PD): A Case Report Pichet Termsarasab, MD
03:00 PM - 06:30 PM	Abstract	046 - Impedance Changes Occur During Threshold Measurements in Deep Brain Stimulation Patients Stephen Carcieri
03:00 PM - 06:30 PM	Abstract	048 - Comorbidities and the Outcome of Deep Brain Stimulation Surgery in Parkinson's disease Faisal A. Alsallom, MD
03:00 PM - 06:30 PM	Abstract	049 - A Multiple-Target DBS strategy for Parkinson's disease. Masa-Aki Higuchi, MD
03:00 PM - 06:30 PM	Abstract	050 - Deep Brain Stimulation of the Nucleus Accumbens has Positive Effects on Parkinson's Disease-related Apathy Nolan Williams, MD
03:00 PM - 06:30 PM	Abstract	051 - Acute Lower Urinary Tract Dysfunction After Bilateral STN Deep Brain Stimulation Surgery For PD: Case Reports And Literature Review Richard Salazar, MD, FAAN
03:00 PM - 06:30 PM	Abstract	052 - Determinants of the Frequency of Post-Operative DBS Office Visits Justin P. Martello, MD, FAAN
03:00 PM - 06:30 PM	Abstract	053 - Contextual Regulation of Simple Decisions in Parkinson's Disease: Effects of STN-DBS and L-Dopa Miguel Ulla, MD, PhD
03:00 PM - 06:30 PM	Abstract	054 - Interleaving could be a better programming technique for Parkinson's disease and Dystonia patients Dennys Reyes, MD
03:00 PM - 06:30 PM	Abstract	055 - Concurrent Bilateral Vim and STN DBS in a Patient with ET/PD Subhashie Wijemanne, MD
03:00 PM - 06:30 PM	Abstract	056 - Comparison of Screening Tools for Assessing Deep Brain Stimulation Candidacy in Parkinson Disease Kelvin L. Chou, MD, FAAN
03:00 PM - 06:30 PM	Abstract	058 - Impact of Socioeconomic Status on Outcome of Deep Brain Stimulation Surgery for Parkinson's Disease Gencer Genc, MD
03:00 PM - 06:30 PM	Abstract	059 - Effect of Dorsal and Ventral Subthalamic Nucleus Deep Brain Stimulation on Actual and Perceived Sense of Postural Balance Jonathan J. Eskenazi Markewitz, MD
03:00 PM - 06:30 PM	Abstract	060 - Dorsal and Ventral Subthalamic Nucleus Deep Brain Stimulation induced Cerebral Blood Flow and Motor Responses Mwiza Ushe, MD
03:00 PM - 06:30 PM	Abstract	061 - Response to IncobotulinumtoxinA After Resistance to OnabotulinumtoxinA and RimabotulinumtoxinB Vesper F. Ramos, MD
03:00 PM - 06:30 PM	Abstract	062 - Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE): Treatment Patterns and Subject Disposition P. D. Charles, MD, FAAN
03:00 PM - 06:30 PM	Abstract	063 - ANCHOR-CD (AbobotulinumtoxinA Neurotoxin: Clinical and Health Economics Outcomes Registry in Cervical Dystonia): A Multicenter, Observational Study of Dysport in Cervical Dystonia: Baseline Data and Cycle One Efficacy Data Daniel D. Truong, MD, FAAN
03:00 PM - 06:30 PM	Abstract	064 - Clinical Audit of the Efficacy of Xeomin against Dysport for the treatment of Dystonia Daveena Meeks
03:00 PM - 06:30 PM	Abstract	065 - The Retrospective Evaluation of the Dose of IncobotulinumtoxinA and OnabotulinumtoxinA for the Clinical Management of Cervical Dystonia and Blepharospasm: TRUDOSE Pilot Study
03:00 PM - 06:30 PM	Abstract	066 - Deep Brain Stimulation In Patients With Primary Dystonia With GNAL Mutation: A Case Series Harini Sarva, MD, FAAN
03:00 PM - 06:30 PM	Abstract	067 - Patient experience of Botulinum toxin injections for dystonia and hemifacial spasm: knowledge of diagnosis and treatment
03:00 PM - 06:30 PM	Abstract	068 - Stability of botulinum toxin A dosage over time in patients with hemifacial spasm, blepharospasm and cervical dystonia/torticollis. Shira McMahan, DO
03:00 PM - 06:30 PM	Abstract	069 - Treatment Outcomes in Cervical Dystonia Patient Registry for Observation of OnabotulinumtoxinA Efficacy (CD PROBE) Joseph Jankovic, MD, FAAN
03:00 PM - 06:30 PM	Abstract	070 - Mayo Clinic Florida collection of human skin fibroblast cultures from patients with hereditary neurodegenerative disorders Zbigniew K. Wszolek, MD, FAAN
03:00 PM - 06:30 PM	Abstract	071 - Changes in troublesome dyskinesia and its relationship with dose in advanced Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion Angelo Antonini, MD
03:00 PM - 06:30 PM	Abstract	072 - Apomorphine Improves Morning Akinesia in Parkinson's Disease: Interim Analysis of the AM-IMPAKT trial Stuart H. Isaacson, MD, FAAN
03:00 PM - 06:30 PM	Abstract	073 - Approach to treatment of depression in Parkinson's disease: Results from NPF-QII Peter T. Schmidt, PhD
03:00 PM - 06:30 PM	Abstract	074 - Pathophysiological Decrease in the Regional Cerebral Blood Flow in Pure Autonomic Failure with Lewy Body Tomoko Takeda, MD
03:00 PM - 06:30 PM	Abstract	075 - Complicated Hereditary Paraplegia with Novel B4GALNT1 Mutations Expanding, the Phenotype and Genotype Saeed A. Bohlega, MD
03:00 PM - 06:30 PM	Abstract	076 - Spinal cord atrophy in Hereditary Spastic Paraplegia caused by SPG4 mutations Lucas D. Branco
03:00 PM - 06:30 PM	Abstract	077 - Cerebral damage in SPG4-hereditary spastic paraplegia (HSP): a VBM study
03:00 PM - 06:30 PM	Abstract	078 - A novel objective brain MRI Assessment Scale for Wilson disease (MAS for WD) Annu Aggarwal, MD
03:00 PM - 06:30 PM	Abstract	079 - Dystonia in Machado-Joseph Disease (MJD/SCA3) is Associated with Thalamic and Brainstem Atrophy Alberto R. Martinez, MD
03:00 PM - 06:30 PM	Abstract	080 - IPX066 Dose Conversion from Immediate-Release Carbidopa-Levodopa, Carbidopa-Levodopa+Entacapone, and Controlled-Release Carbidopa-Levodopa in Patients with Advanced Parkinson's Disease (PD) Ann F. Hsu, PhD, PharmD
03:00 PM - 06:30 PM	Abstract	081 - Long-Term Safety and Maintenance of Efficacy From an Open-Label Extension of the Double-Blind Pivotal Study of Levodopa-Carbidopa Intestinal Gel (LCIG) in Advanced Parkinson's Disease Patients Hubert H. Fernandez, MD, FAAN
03:00 PM - 06:30 PM	Abstract	082 - Improved Motor Performance Associated with Smoother Levodopa Time-Concentration Profiles with DM-1992, a Gastroretentive, Extended-Release Carbidopa/Levodopa Tablet, in Patients with Advanced Parkinson's Disease Leonard Verhagen Metman, MD, PhD
03:00 PM - 06:30 PM	Abstract	083 - Safety Analyses from Open-Label Clinical Trials of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson's Disease: Events Not Related to Device or Procedure Anthony E. Lang, MD, FAAN
03:00 PM - 06:30 PM	Abstract	084 - OPTIPUMP: Different Treatment Strategies Using Continuous Apomorphine Pump Therapy in Parkinsonian Patients and Their Influence on Patient Quality of Life. A French 6 Months, 145 Patients, Propective, Multicentre, Observational Study Sophie Drapier, MD
03:00 PM - 06:30 PM	Abstract	085 - Gastrointestinal Safety of the Levodopa-Carbidopa Intestinal Gel Delivery System in Treating Advanced Parkinson's Patients Michael Epstein
03:00 PM - 06:30 PM	Abstract	086 - A Novel Approach to Treating Impulse Control Disorders (ICDs) in Parkinson's Disease (PD) - A Case Series John Liang, MD
03:00 PM - 06:30 PM	Abstract	087 - Phase-3 Clinical Trials of Adjunctive Therapy with Preladenant, an Adenosine 2a Antagonist, in Patients with Parkinson's Disease Robert A. Hauser, MD, MBA, FAAN
03:00 PM - 06:30 PM	Abstract	088 - Post-hoc Analyses of Phase-3 Data with Preladenant, an Adenosine 2a Antagonist, in Patients with Parkinson's Disease Olivier Rascol, MD, PhD
03:00 PM - 06:30 PM	Abstract	090 - The Effect of Intravenous Immunoglobulin on Regulatory T Cells and Disability Progression in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy Jason R. Thonhoff, MD
03:00 PM - 06:30 PM	Abstract	091 - Anti-TNF alpha-Induced Neuropathies Pinelopi Tsouni
03:00 PM - 06:30 PM	Abstract	092 - Multicentre, Randomised, Open-Label Trial To Compare Efficacy And Tolerance Of Prednisone And IVIG In Patients With CIDP On A One Year Follow Up Jean-Phillippe Camdessanche
03:00 PM - 06:30 PM	Abstract	093 - Small Fiber Neuropathy in Sarcoidosis: The Cleveland Clinic Experience Zubair Ahmed, MD
03:00 PM - 06:30 PM	Abstract	094 - Effect of Agmatine Sulfate on neuropathic pain Vahid Tohidi, MD, PhD
03:00 PM - 06:30 PM	Abstract	095 - Assessment of 2 Patients with Myotonia Congenita Following Intravenous Lidocaine Treatment Saugat Dey, MD
03:00 PM - 06:30 PM	Abstract	096 - Angiotensin Receptor Blockade Can Ameliorate Peripheral Nerve Inflammation in Experimental Autoimmune Neuritis Toshiki Fujioka, MD
03:00 PM - 06:30 PM	Abstract	097 - Agomelatine increases muscle strength and reduces the expression of inflammatory cytokines in mdx dystrophic mice Alzira A. Carvalho, MD
03:00 PM - 06:30 PM	Abstract	098 - Assessment of Bulbar Function in ALS Clinical Trials Richard A. Smith, MD
03:00 PM - 06:30 PM	Abstract	099 - Ig Treatment Outcomes Assessment and Clinical Guidelines Study (the “INSIGHTS Study”): Preliminary Findings on Scope of Practice from the INSIGHTS Database Todd D. Levine, MD
03:00 PM - 06:30 PM	Abstract	100 - Trends in Outcome and Cost of Hospitalization of Elderly Myasthenia Gravis Patients from 1992 to 2009 Data from Nationwide Inpatient Survey (NIS)1997-2009 Andrew Ji
03:00 PM - 06:30 PM	Abstract	101 - Racial and Ethnic Differences across Amyotrophic Lateral Sclerosis (ALS) Cases from Three State and Eight Metropolitan Area Surveillance Projects Lindsay Rechtman
03:00 PM - 06:30 PM	Abstract	102 - Profile of Medical Care Costs in Patients with Amyotrophic Lateral Sclerosis in Medicare Program and under Commercial Insurance Lisa Meng
03:00 PM - 06:30 PM	Abstract	103 - Is Intravenous Immunoglobulin More Cost Effective Than Plasmapheresis in Treatment of Pediatric Myasthenia Gravis Patients? -Data from Kids' Inpatient Database (KID) and Nationwide Inpatient Sample (NIS) Ankit Pahwa
03:00 PM - 06:30 PM	Abstract	104 - The Safety Profile of Home Infusion of Intravenous Immunoglobulin in Neuroimmunological Disorders Ankit Pahwa
03:00 PM - 06:30 PM	Abstract	105 - Trends in Outcome and Cost of Hospitalization of Adult Myasthenia Gravis. Data Analysis from Nationwide Inpatient Survey (NIS) from 1992 to 2009 Wenzhuan He, MD
03:00 PM - 06:30 PM	Abstract	106 - ALD Connect, an all-inclusive consortium to improve care and drug discovery for X-linked adrenoleukodystrophy Florian Eichler, MD
03:00 PM - 06:30 PM	Abstract	107 - Con-focal Microscopy Documents Significant Epidermal Nerve Demyelization in Patients With Clinical Neuropathy But Normal Neurophysiologic Studies Amiram Katz, MD
03:00 PM - 06:30 PM	Abstract	108 - Validation of disease-specific patient reported outcomes in the home environment Gretchen A. Ayer, MS
03:00 PM - 06:30 PM	Abstract	109 - Axonal GBS in a Midwest medical center; clinical characteristics and outcome Muna Irfan, MD
03:00 PM - 06:30 PM	Abstract	110 - Recommended Cut-Off Values for Diagnosis of Carpal Tunnel Syndrome Using Ultrasonography in Females
03:00 PM - 06:30 PM	Abstract	111 - Efficacy and Safety of Home Infusion of Intravenous Immunoglobulin in Multifocal Motor Neuropathy: A longitudinal study. Gretchen A. Ayer, MS
03:00 PM - 06:30 PM	Abstract	113 - A retrospective analysis of patient-reported outcomes for 34 patients with Stiff Person Syndrome receiving home IVIG infusions. Shafeeq Ladha, MD
03:00 PM - 06:30 PM	Abstract	114 - Electrophysiological Motor Unit Function in SMN?7 Mice Following SMN Restoration William D. Arnold, MD
03:00 PM - 06:30 PM	Abstract	115 - Neuropathy Signs and Tests in Therapeutic Trials of Transthyretin Amyloidosis Polyneuropathy Narupat Suanprasert
03:00 PM - 06:30 PM	Abstract	116 - Retrospective Review of Patients with Sciatic nerve palsy after Total Joint Arthoplasty Teena Shetty, MD, FAAN
03:00 PM - 06:30 PM	Abstract	117 - Perceived Fatigue and Physiological Fatigue in Spinal Muscular Atrophy (SMA): Are They Related? Sally Dunaway, DPT
03:00 PM - 06:30 PM	Abstract	119 - Predictors of Hemorrhagic Transformation of Acute Ischemic Stroke: Prospective Validation of a Hemorrhage Risk Model Elisabeth B. Marsh, MD, FAAN
03:00 PM - 06:30 PM	Abstract	120 - The Western States Stroke Consortium Telestroke Project Gene Y. Sung, MD, MPH
03:00 PM - 06:30 PM	Abstract	121 - “Tele” Phone Medicine - Is Hearing Enough? Rebecca L. Sugg, MD, FAAN
03:00 PM - 06:30 PM	Abstract	122 - Why ischemic stroke patients do not receive thrombolytic treatment? Sourabh Lahoti, MD
03:00 PM - 06:30 PM	Abstract	124 - Cerebral Ischemic Events Associated with Intravenous Thrombolytic Administration in International Joint Efficacy Comparison of Thrombolytics (INJECT) Trial
03:00 PM - 06:30 PM	Abstract	125 - A smartphone application to aid in the evaluation, treatment, and clinical trial enrollment of the acute stroke patient Claude Nguyen, MD
03:00 PM - 06:30 PM	Abstract	126 - Where are opportunities to increase intravenous thrombolysis in current practice? George E. Koch
03:00 PM - 06:30 PM	Abstract	127 - Intravenous thrombolysis onset to treatment time has a small effect on in-hospital outcomes in acute ischemic stroke Konark Malhotra, MD
03:00 PM - 06:30 PM	Abstract	129 - An initiative to improve door to needle time for stroke thrombolysis in Chicago Shyam Prabhakaran, MD
03:00 PM - 06:30 PM	Abstract	130 - Quality Improvement Project: Improving the Time To Treatment in Inpatient Acute Ischemic Stroke Rocio C. Garcia Santibanez, MD, FAAN
03:00 PM - 06:30 PM	Abstract	131 - The Presence of Neurology impacting Door to Needle time in Acute Stroke Donna George, MD
03:00 PM - 06:30 PM	Abstract	132 - Perception of stroke symptoms and utilization of emergency medical systems in Argentina Maximiliano A. Hawkes, MD
03:00 PM - 06:30 PM	Abstract	133 - Awareness of Stroke and Knowledge of its Warning Signs and Risk Factors in a Developing Country
03:00 PM - 06:30 PM	Abstract	134 - Stroke Awareness In Aseer Region, Community Based Cross Sectional Study Adel Alhazzani, MD, FRCPC, FAAN
03:00 PM - 06:30 PM	Abstract	135 - Stroke awareness among community residents in Chicago
03:00 PM - 06:30 PM	Abstract	136 - Hyperacute Neurologic Changes and Outcome after Intracerebral Hemorrhage Matthew B. Maas, MD, FAAN
03:00 PM - 06:30 PM	Abstract	137 - Body Mass Index and Intracerebral Hemorrhage Stephanie Holmes
03:00 PM - 06:30 PM	Abstract	138 - Predictors of inpatient mortality after intracerebral hemorrhage. Analysis of US Nationwide inpatient sample database. Vijayakumar Javalkar, MD, FAAN
03:00 PM - 06:30 PM	Abstract	140 - Risk factors and outcomes of prolonged hospitalization after intracerebral hemorrhage in United States Yogesh Moradiya, MD
03:00 PM - 06:30 PM	Abstract	141 - Antiplatelet drugs resumption after antiplatelet-related intracerebral hemorrhage in Chinese Kay Cheong Teo, MD
03:00 PM - 06:30 PM	Abstract	142 - Warfarin associated intracerebral hemorrhage in Hong Kong Chinese Kay Cheong Teo, MD
03:00 PM - 06:30 PM	Abstract	143 - Blood Transfusion Does Not Improve Outcomes in Patients with Spontaneous Intracerebral Hemorrhage Wazim Mohamed, MD
03:00 PM - 06:30 PM	Abstract	144 - Seasonal variation in the incidence and mortality of Intracerebral hemorrhage. Anand V. Patel, MD
03:00 PM - 06:30 PM	Abstract	145 - Intracerebral hematoma volume measurement using ITK-SNAP software: Initial experience Monika Mishra, MD
03:00 PM - 06:30 PM	Abstract	146 - Natural Autoantibodies in the Serum of Post-stroke patients with Different Clinical Outcomes Alla Borisovna Guekht, PhD
03:00 PM - 06:30 PM	Abstract	147 - Impact of stroke location on stroke outcome Archana Hinduja, MD
03:00 PM - 06:30 PM	Abstract	149 - Predictors of Outcome in Patients with Acute M2 Occlusion Muhib Khan, MD, FAAN
03:00 PM - 06:30 PM	Abstract	150 - Elderly Non-Demented Patients Have Better Outcome with Reperfusion Therapy Than Demented Patients Following Ischemic Stroke Iftekhar Ahmed, MD, PC, FAAN
03:00 PM - 06:30 PM	Abstract	151 - Diastolic Function of Heart and Outcomes After Ischemic Stroke Ahn Hee Seung
03:00 PM - 06:30 PM	Abstract	152 - Combined Elevation of FVIII and von Willebrand Factor Predicts Risk for Worse Outcomes in Patients with Acute Ischemic Stroke (AIS) Alyana Samai
03:00 PM - 06:30 PM	Abstract	153 - Leukoaraiosis is associated with impaired functional recovery and outcome after mild ischemic stroke. Sanjeeva R. Onteddu, MD, FAAN
03:00 PM - 06:30 PM	Abstract	154 - Does the Magnitude of the Electrocardiogram QT Interval Dispersion Predict Stroke Outcome? Yitzchok Lederman
03:00 PM - 06:30 PM	Abstract	155 - Areas of Cerebral Ischemia Have Increased Propensity to Convert to Infarct among Diabetics Wazim Mohamed, MD
03:00 PM - 06:30 PM	Abstract	156 - Return to Driving Following Stroke Shelly D. Ozark, MD
03:00 PM - 06:30 PM	Abstract	158 - NIHSS Score May Help Predict Health Literacy Levels after Acute Ischemic Stroke Kalina M. Sanders, MD
03:00 PM - 06:30 PM	Abstract	159 - Dysphagia in Patients with Acute Ischemic Stroke Mohamed Al-Khaled
03:00 PM - 06:30 PM	Abstract	160 - Relative importance of stroke sequelae according to patients and caregivers. Victor C. Urrutia, MD
03:00 PM - 06:30 PM	Abstract	162 - The Association of Clinical Factors and Highly-Sensitive C-Reactive Protein (hsCRP) with Depression in Stroke Patients Ahmed Itrat, MD
03:00 PM - 06:30 PM	Abstract	164 - Correlation of NIH Stroke Scale Change and Vascular Risk Factors in Acute Stroke Patients Prashanth Krishnamohan, MD
03:00 PM - 06:30 PM	Abstract	165 - Rates and Predictors of Five Year Survival in Asymptomatic Medicare Beneficiaries Undergoing Carotid Revascularization Muhammad F. Suri, MD
03:00 PM - 06:30 PM	Abstract	166 - Influence of CREST on CEA and CAS trends in women - do the results matter? Shahram Khalid, MD
03:00 PM - 06:30 PM	Abstract	168 - Basilar TIAs of Symptomatic Carotid Artery Stenosis Felix M. Veloso, MD, FAAN
03:00 PM - 06:30 PM	Abstract	169 - Symptomatic Carotid Near-Occlusion With String Sign Incurs A Very High Risk Of Stroke Elias Johansson
03:00 PM - 06:30 PM	Abstract	170 - Carotid Artery Stenosis And Randomized Controlled Trials - Should We Abandon The Gold Standard
03:00 PM - 06:30 PM	Abstract	172 - Are Carotid Artery Stenosis-Isolated and Carotid Artery-Plus Two Distinct Entities? Vishal Jani, MD
03:00 PM - 06:30 PM	Abstract	173 - Pituitary apoplexy: an unusual complication of carotid endarterectomy Sandrine Jeangette
03:00 PM - 06:30 PM	Abstract	174 - Association of Resting Heart Rate With Cerebrovascular Risk Factors And Carotid Artery Stenosis. Syed I. Hussain, MD
03:00 PM - 06:30 PM	Abstract	175 - Assessment of Cardiovascular Safety in Cynomolgus Monkeys Following IV Administration of LBR-101
03:00 PM - 06:30 PM	Abstract	176 - Spinning Out of Control: The Black Box of Basilar and Hemiplegic Migraine Regina Krel, MD
03:00 PM - 06:30 PM	Abstract	177 - Randomized Controlled Trial: Targeted Neck Cooling in the Treatment of the Migraine Patient Adam S. Sprouse-Blum, MD
03:00 PM - 06:30 PM	Abstract	178 - Successful Treatment of Spontaneous Low-Pressure Headache Due to Prominent Cervical CSF Leak with Cervical Epidural Blood Patch Eugene Wang, MD
03:00 PM - 06:30 PM	Abstract	179 - Intranasal Capsaicin (IC) rapidly relieves the pain of Migraine and other severe Headaches Maria E. Alexianu, MD, PhD
03:00 PM - 06:30 PM	Abstract	180 - An Inpatient Course Of Intravenous Dihydroergotamine Use For New Daily Persistent Headache Michael Eller, MD
03:00 PM - 06:30 PM	Abstract	181 - Cerebral Blood Flow Velocity in Migraine and Tension- Type Headache Patients
03:00 PM - 06:30 PM	Abstract	182 - A Randomized, Open-Label, Parallel Two-Arm Study Evaluating the Efficacy of H.P. Acthar Injection Gel in the Treatment of Adults with Intractable Chronic Migraine Laszlo Mechtler, MD, FASN, FAAN
03:00 PM - 06:30 PM	Abstract	183 - Trigeminal trophic syndrome with intractable pain, successfully treated with spinal cord stimulation Erin C. Golden, MD
03:00 PM - 06:30 PM	Abstract	184 - Incidence of Adverse Events with MAP0004 Does Not Increase with Increased Frequency of Dosing: Results from a Long-Term Phase 3 Study Paul Winner, DO, FAAN
03:00 PM - 06:30 PM	Abstract	185 - SUNCT Syndrome Responding to OnabotulinumtoxinA Injections: A Case Report Jina M. Youn, MD, MS
03:00 PM - 06:30 PM	Abstract	186 - The Durability of OnabotulinumtoxinA for the Treatment of Chronic Migraine: CLARITY Pilot Study Andrew M. Blumenfeld, MD, FAAN
03:00 PM - 06:30 PM	Abstract	187 - Headache and treatment of unruptured intracranial aneurysms Julieta E. Arena, MD
03:00 PM - 06:30 PM	Abstract	188 - Incobotulinumtoxin A for the preventive treatment of chronic migraine headaches Patrick M. Grogan, MD, FAAN
03:00 PM - 06:30 PM	Abstract	189 - The IV Pharmaokinetics of Single and Multiple Doses of LBR-101 in Healthy Volunteers
03:00 PM - 06:30 PM	Abstract	190 - Safety and Tolerability of LBR-101, a Humanized Monoclonal Antibody That Blocks the Binding of CGRP to Its Receptor - Results of the Phase 1 Program Rafael Escandon
03:00 PM - 06:30 PM	Abstract	193 - Lamotrigine as a Prophylactic Treatment for Migraine-Associated Vertigo: A Case Series Lixin Zhang, MD, PhD
03:00 PM - 06:30 PM	Abstract	194 - A Critical Evaluation of Migraine Trigger Site Deactivation Surgery Paul G. Mathew, MD, FAHS, FAAN
03:00 PM - 06:30 PM	Abstract	195 - Cardiac Side Effects of Dihydroergotamine Erin Bange
03:00 PM - 06:30 PM	Abstract	196 - Gammacore device for treatment of Migraine attack: preliminary data Licia Grazzi, MD
03:00 PM - 06:30 PM	Abstract	197 - Transient Exacerbation Of Headache In Patients Receiving Intravenous Dihydroergotamine For Inpatient Management Of Chronic Migraine Does Not Alter Outcomes Michael Eller, MD
03:00 PM - 06:30 PM	Abstract	198 - Cardiovascular and Hemodynamic Parameters in Women Following IV Administration of LBR-101, a Monoclonal Antibody Against CGRP Marcelo E. Bigal, MD, PhD
03:00 PM - 06:30 PM	Abstract	199 - Efficacy and safety of high dose of intravenous methylprednisolone in cluster headache patients not responders to oral therapy
03:00 PM - 06:30 PM	Abstract	200 - Safety of Dihydroergotamine Use in Patients with Symptoms of Hemiplegic or Basilar Type Migraine Brad C. Klein, MD, MBA, FAAN
03:00 PM - 06:30 PM	Abstract	201 - Long Term Therapeutic Response of Sphenopalatine Ganglion (SPG) Stimulation for Cluster Headache - Pathway CH-1 Study Miguel J. Lainez, MD, PhD, FAAN
03:00 PM - 06:30 PM	Abstract	202 - Peripheral Nerve Blocks for Pregnant Patients with Headache
03:00 PM - 06:30 PM	Abstract	203 - Efficacy and Safety of AVP-825, a Novel Breath-PoweredTM Powder Sumatriptan Intranasal Treatment, for Acute Migraine
03:00 PM - 06:30 PM	Abstract	204 - Initial Management of Migraine Headaches with Oral Medications in a Pediatric Emergency Unit Bhooma R. Aravamuthan, MD, PhD
03:00 PM - 06:30 PM	Abstract	205 - An Observational Comparison Of Natalizumab & Fingolimod Using JCV Serology To Randomize Therapy Robert L. Carruthers, MD
03:00 PM - 06:30 PM	Abstract	206 - Fingolimod is Not Able to Inhibit Multiple Sclerosis Disease Reactivation after Natalizumab Discontinuation Marco Capobianco, MD
03:00 PM - 06:30 PM	Abstract	207 - Stopping Disease Modifying Therapy in Progressive Multiple Sclerosis - A Prospective Study Gary Birnbaum, MD, FAAN
03:00 PM - 06:30 PM	Abstract	208 - Comparison of Switching to Natalizumab Versus Remaining on Interferon-Beta or Glatiramer Acetate after On-Treatment MS Relapse Using Propensity-Matched Registry Data Timothy Spelman
03:00 PM - 06:30 PM	Abstract	209 - Natalizumab in Multiple Sclerosis with Spinal Involvement
03:00 PM - 06:30 PM	Abstract	210 - Impact of Natalizumab Treatment for Multiple Sclerosis on Patient-Reported Physical Functioning over 3 Years in US Clinical Practices Timothy L. Vollmer, MD, FAAN
03:00 PM - 06:30 PM	Abstract	211 - Relapse rates among patients with multiple sclerosis who switch from interferon therapy to fingolimod or glatiramer acetate: a retrospective US claims database analysis
03:00 PM - 06:30 PM	Abstract	212 - Reactivation during switch from natalizumab to fingolimod: is it predictible? Adil Maarouf
03:00 PM - 06:30 PM	Abstract	213 - Multiple Sclerosis Symptom Recrudescence Is Common At The End Of The Natalizumab Dosing Cycle John Ratchford, MD
03:00 PM - 06:30 PM	Abstract	214 - Estimating the Onset of Efficacy With Teriflunomide in Patients With Relapsing Forms of Multiple Sclerosis Jerry S. Wolinsky, MD, FAAN
03:00 PM - 06:30 PM	Abstract	215 - A five-year clinical follow-up study of patients with multiple sclerosis who started natalizumab Luca Prosperini, MD
03:00 PM - 06:30 PM	Abstract	216 - Natalizumab Therapy, How to Treat How to Stop: The TY-STOP Study Marinella Clerico, MD
03:00 PM - 06:30 PM	Abstract	217 - Recommendations for Fingolimod Treated Patients Vacinated for Varicella Zoster Virus. Sergio Stecchi, MD
03:00 PM - 06:30 PM	Abstract	218 - Treatment Satisfaction After Switching To Fingolimod Directly From An Injectable Therapy Edward Fox, MD, PhD, FAAN
03:00 PM - 06:30 PM	Abstract	219 - Adherence To, And Effectiveness Of, Treatment With Subcutaneous Interferon Beta-1a In Relapsing Multiple Sclerosis Patients Using RebiSmart™ For Self-Injection: Final Results Of The One-Year International, Observational SMART Study Antonios Bayas
03:00 PM - 06:30 PM	Abstract	220 - Improved Estimation Of Treatment Effects: Analysis Of Time To Recurrent Relapse With Fingolimod Or Intramuscular Interferon Beta-1a Treatment Using The Proportional Means Model Xiangyi Meng, PhD
03:00 PM - 06:30 PM	Abstract	221 - Switching from Injectable Therapy Leads to High Continuation Rate on Fingolimod Yves L. Lapierre, MD
03:00 PM - 06:30 PM	Abstract	222 - Relapse rates among patients with a history of relapses treated with fingolimod compared with interferons or glatiramer acetate for the treatment of multiple sclerosis: a retrospective US claims database analysis
03:00 PM - 06:30 PM	Abstract	223 - Efficacy of fingolimod therapy does not dependent on the individual body mass index in patients with MS Thomas Dehmel
03:00 PM - 06:30 PM	Abstract	224 - Positive Response to Alemtuzumab (ALE) Rescue Immunotherapy in a High disability, Treatment-Refractory Multiple Sclerosis (MS) Cohort Samuel F. Hunter, MD, PhD
03:00 PM - 06:30 PM	Abstract	225 - Persistence and adherence of fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis
03:00 PM - 06:30 PM	Abstract	226 - Clinical Predictors for Fingolimod (Gilenya) Treatment Response in Multiple Sclerosis Patients Dalia Rotstein, MD
03:00 PM - 06:30 PM	Abstract	227 - Changes in Natalizumab Treatment Patterns and Association with Relapse Outcomes: A Retrospective Study
03:00 PM - 06:30 PM	Abstract	228 - A Two-Year Retrospective Analysis Of Rituximab Therapy In Secondary-Progressive Multiple Sclerosis Christopher Perrone, MD
03:00 PM - 06:30 PM	Abstract	229 - Marburg Variant Multiple Sclerosis, Responsive to Natalizumab Acutely and Chronically Sara A. Mayer, MD
03:00 PM - 06:30 PM	Abstract	230 - Fingolimod Treatment In Relapsing-Remitting Multiple Sclerosis Patients: A Clinical Practice Experience Rocco Totaro, MD
03:00 PM - 06:30 PM	Abstract	231 - Prospective Evaluation of Persistence, Treatment Adherence, Quality of Life, and Treatment Satisfaction in Patients Treated with an Intramuscular Interferon Beta-1a Autoinjector in a Real-World Clinical Setting Antonio V. Salgado, MD
03:00 PM - 06:30 PM	Abstract	232 - Comparison of Efficacy and Treatment Satisfaction of Patients on Baseline Therapy or Fingolimod: Results of the Interim Analysis of Two German Registry Studies PANGAEA and PEARL Tjalf Ziemssen, MD, FAAN
03:00 PM - 06:30 PM	Abstract	233 - Fingolimod first-dose effects in patients with relapsing-remitting multiple sclerosis concomitantly treated with serotonin-specific reuptake inhibitors Robert A. Bermel, MD, FAAN
03:00 PM - 06:30 PM	Abstract	234 - Systematic Literature Review and Network Meta-Analysis of Pegylated Interferon Beta-1a and Disease Modifying Therapies for Relapsing-Remitting Multiple Sclerosis
03:00 PM - 06:30 PM	Abstract	235 - Treatment Satisfaction, Adherence and Behavioural Assessment in Patients De - escalating from Natalizumab To Interferon Beta
03:00 PM - 06:30 PM	Abstract	236 - The Providence Ms Center's Dimethyl Fumarate (DMF) Registry Kyle Smoot, MD, FAAN
03:00 PM - 06:30 PM	Abstract	237 - Pharmacokinetics of Laquinimod, an Oral Immunomodulatory Agent in Development for The Treatment of Relapsing-Remitting Multiple Sclerosis Hayrettin Tumani, MD
03:00 PM - 06:30 PM	Abstract	238 - Clinical And Radiological Activity During The Fingolimod Treatment Prescribed After Natalizumab. A Multiple Sclerosis Unit Experience Rocio Hernandez Clares, MD, PhD
03:00 PM - 06:30 PM	Abstract	239 - Safety and efficacy in patients receiving natalizumab therapy in Hungary Tunde Csepany, MD
03:00 PM - 06:30 PM	Abstract	240 - Subcutaneous Interferon Beta-1a Decreases the Evolution of Gadolinium-Enhancing Lesions Into Chronic Black Holes in Relapsing Multiple Sclerosis Anthony Traboulsee, MD
03:00 PM - 06:30 PM	Abstract	241 - Risk Factors for Relapses After Switching From Natalizumab To Fingolimod Joachim Havla, MD
03:00 PM - 06:30 PM	Abstract	242 - Short Term Follow Up Of Central Motor Conduction Failure In Relapsing Multiple Sclerosis Patients Undergoing High Dose Steroids Treatment Alessia Di Sapio, MD
03:00 PM - 06:30 PM	Abstract	243 - Epidemiological Study To Identify Factors That Influence Clinical Decision Making In Patients With Relapsing Remitting Multiple Sclerosis (RRMS) After At Least 2 Years Of Treatment With Immunomodulators In Germany (EPIDEM)
03:00 PM - 06:30 PM	Abstract	244 - Dalfampridine Real World Utilization and Efficacy Assessment Sylvia Klineova, MD
03:00 PM - 06:30 PM	Abstract	245 - Aspirin is Unlikely to Have A Clinically Meaningful Effect on Multiple Sclerosis-Related Fatigue: Data From a Randomized Controlled Trial Dean M. Wingerchuk, MD, FAAN
03:00 PM - 06:30 PM	Abstract	246 - Effects Of Prolonged-Released Fampridine On Walking Parameters, Upper Limb Function, Fatigue And Quality Of Life
03:00 PM - 06:30 PM	Abstract	247 - Prolonged-release fampridine (Fampyra®) post-marketing experience in the Alsace region
03:00 PM - 06:30 PM	Abstract	248 - Long-Term Course and Clinical Assessment Parameters of Patients With Multiple Sclerosis Under Dalfampridine Tobias Ruck
03:00 PM - 06:30 PM	Abstract	249 - Monotherapy with THC/CBD Spray in Multiple Sclerosis Induced Spasticity Juergen Koehler, MD
03:00 PM - 06:30 PM	Abstract	250 - Use of Medical Marijuana for Symptoms of Multiple Sclerosis (MS) among Participants of the Pacific Northwest MS Registry (PNWMSR) Tamela Stuchiner
03:00 PM - 06:30 PM	Abstract	251 - Attenuation of Dimethyl fumarate-related gastrointestinal symptoms with Montelukast Carlo S. Tornatore, MD
03:00 PM - 06:30 PM	Abstract	252 - 25G Sprotte needle strongly reduces the risk of post-lumbare puncture headache in clinical practice. Antonio Bertolotto, MD, FAAN
03:00 PM - 06:30 PM	Abstract	253 - A Double-Blind Placebo Controlled Study of the Effect of Beta-Alanine, a Nonessential Amino-Acid, on Neurologic, Motor Function, Quality of Life, and Fatigue in Patients Diagnosed With Multiple Sclerosis John H. Kanter
03:00 PM - 06:30 PM	Abstract	254 - Brain metastases in ovarian cancer- A comprehensive review .
03:00 PM - 06:30 PM	Abstract	255 - A case of Primary Meningeal Melanoma Bhaskar Roy, MD, FAAN
03:00 PM - 06:30 PM	Abstract	256 - Isolated Primary CNS Infiltrative Parenchymal Histiocytosis with Intraventricular Hemorrhage Eric Mittelmann, MD
03:00 PM - 06:30 PM	Abstract	257 - Brainstem Glioma 8 Years After External Beam Radiotherapy for Pituitary Macroadenoma: Correlation with Radiation Treatment Dose and Volume Salim Abboud
03:00 PM - 06:30 PM	Abstract	258 - Effects of Ionizing Radiation on Human Microglial Cells
03:00 PM - 06:30 PM	Abstract	259 - Salvage Therapy with Bendamustine for Methotrexate Refractory Recurrent Primary CNS Lymphoma: A Retrospective Case Series Marc Chamberlain, MD
03:00 PM - 06:30 PM	Abstract	260 - Primary Natural Killer/T-cell Lymphoma Presenting as Leptomeningeal Disease Bing Liao, MD
03:00 PM - 06:30 PM	Abstract	261 - Rituximab and Bendamustine for CNS involvement by Chronic Lymphocytic Leukemia Geraldine Faivre, MD
03:00 PM - 06:30 PM	Abstract	262 - Neurolymphomatosis: Heterogenous Presentations Daniel Winkel, MD
03:00 PM - 06:30 PM	Abstract	263 - VEGF and Pentraxin-3 Levels in POEMS Syndrome: a 2-Year Longitudinal Study. Chiara Dalla Torre
03:00 PM - 06:30 PM	Abstract	264 - Bing-Neel Syndrome: Presentation of Three Unusual Patients Louis Royer-Perron, MD
03:00 PM - 06:30 PM	Abstract	266 - Hormone Replacement Therapy and Risk of Glioma: A Nationwide Nested Case-Control Study Lene Andersen
03:00 PM - 06:30 PM	Abstract	267 - Relationship between CD44v6 and E-cadherin expression in human primary brain tumors Leslaw Zub
03:00 PM - 06:30 PM	Abstract	268 - A Novel Therapeutic Target for Treatment of Malignant Brain Tumors Nazanin K. Majd, MD
03:00 PM - 06:30 PM	Abstract	269 - Posterior fossa recurrences of supratentorial WHO grade II and III gliomas Robert Terziev
03:00 PM - 06:30 PM	Abstract	271 - Oligodendroglial gliomatosis cerebri exhibiting leptomeningeal and nerve root involvement Grace M. McMacken, MD
03:00 PM - 06:30 PM	Abstract	272 - A Case Report: Primary Glioblastoma of the Pineal Regina Krel, MD
03:00 PM - 06:30 PM	Abstract	273 - Aggressive Medical Care at the End of Life (EOL) in Glioblastoma (GBM): The 5-year Memorial Sloan-Kettering Cancer Center (MSKCC) Experience Alexis M. Dallara-Marsh, MD
03:00 PM - 06:30 PM	Abstract	274 - Neuro-oncology Telemedicine Follow-up Visits Richard M. Green, MD, FAAN
03:00 PM - 06:30 PM	Abstract	275 - Outcome of Intracranial EEG Monitoring and Surgery in MRI-negative Temporal Lobe Epilepsy Ricky Lee, MD
03:00 PM - 06:30 PM	Abstract	276 - Comparison of Seizure Outcome after Selective Amygdalohippocampectomy in Adult versus Pediatric Onset Temporal Lobe Seizures Aradia Fu, MD
03:00 PM - 06:30 PM	Abstract	277 - Reasons for Delayed Temporal Lobe Epilepsy Surgery Aditi Narechania, MD
03:00 PM - 06:30 PM	Abstract	278 - Surgical Outcome of Parietal Lobe Epilepsy Anna-Marieta Moise, MD
03:00 PM - 06:30 PM	Abstract	280 - Deep brain stimulation for the management of seizures in MECP2 duplication syndrome. Fabio Nascimento, MD
03:00 PM - 06:30 PM	Abstract	281 - The Efficacy of VNS in Patients With Pharmacoresistant Epilepsy of Temporal Versus Extra-Temporal Locations Abuhuzeifa Abubakr, MB, FRCP, FRCPI, FAAN
03:00 PM - 06:30 PM	Abstract	282 - Prospective Memory After Mesial Temporal Resection
03:00 PM - 06:30 PM	Abstract	283 - Database Systems and Online Tools for Early referral to Epilepsy Surgery Evaluation in Mesial Temporal Lobe Epilepsy Rodolfo C. Callejas-Rojas, MD
03:00 PM - 06:30 PM	Abstract	284 - Association between Chronobiology of Seizures and Hemispheric Laterality in Patients who Underwent Surgery for Refractory Epilepsy Anca S. Popescu, MD, FAAN
03:00 PM - 06:30 PM	Abstract	285 - Vagal Nerve Stimulation and Cortical Source Localization in Pre- and Post-Operation EEG Data: A Case Study Ahmet Hakan Ekmekci, PhD
03:00 PM - 06:30 PM	Abstract	286 - Memantine Effects on Attention in FXTAS: a Double-blind ERP Study Jinchen Yang, PhD
03:00 PM - 06:30 PM	Abstract	287 - The Mind's Eye: Effects of Aging, Hemispace and Movement Direction on Estimates of Distance Tigran Kesayan, MD
03:00 PM - 06:30 PM	Abstract	288 - Predictors of Recovery of Allocentric and Egocentric Neglect: the Role of Education Joseph Posner
03:00 PM - 06:30 PM	Abstract	289 - Spatial Neglect Commonly Occurs after Traumatic Brain Injury Peii Chen
03:00 PM - 06:30 PM	Abstract	290 - Changes of Vertical and Horizontal Pseudoneglect with Aging Nicholas Milano, MD
03:00 PM - 06:30 PM	Abstract	291 - Effects of Gaze, Head and Hand Location on Motor Function: Evidence from TMS in Normal Subjects Harry B. Coslett, MD, FAAN
03:00 PM - 06:30 PM	Abstract	292 - Things Look Up With Aging
03:00 PM - 06:30 PM	Abstract	293 - Leftward Where bias and rightward distraction in chronic neglect. A. M. Barrett, MD, FAAN
03:00 PM - 06:30 PM	Abstract	294 - Spatial neglect and Parkinson disease Adam D. Falchook, MD
03:00 PM - 06:30 PM	Abstract	295 - Apparent Body Size Alters Motor Function Harry B. Coslett, MD, FAAN
03:00 PM - 06:30 PM	Abstract	296 - Central nervous system safety and tolerability of DS-5565: a randomized, double-blind, placebo- and active comparator-controlled phase II study in diabetic peripheral neuropathic pain Aaron Vinik
03:00 PM - 06:30 PM	Abstract	297 - Pharmacologic and Non-Pharmacologic Treatments of Adolescents with Chronic Tension-type Headache. Peter Przekop, DO, PhD
03:00 PM - 06:30 PM	Abstract	298 - Efficacy Of Pregabalin In The Treatment Of Prediabetic Neuropathic Pain Maria Alejandra Gonzalez Duarte, MD, FAAN
03:00 PM - 06:30 PM	Abstract	299 - Emergence of new responders to treatment and new adverse events in clinical trials of pregabalin in diabetic peripheral neuropathy and postherpetic neuralgia B. Parsons
03:00 PM - 06:30 PM	Abstract	300 - Contact Heat Evoked Potentials Stimulator (CHEPS) In The Assessement Of Painful Leprosy Neuropathy Camila Pupe, MD
03:00 PM - 06:30 PM	Abstract	301 - Pharmacological, Pharmacokinetics and Safety Profiles of DS-5565, a Novel ?2? Ligand Tomihisa Yokoyama
03:00 PM - 06:30 PM	Abstract	302 - An Assessment Of Pain Reports In Amyotrophic Lateral Sclerosis Using Three Large Data Sets Helen E. Stephens
03:00 PM - 06:30 PM	Abstract	303 - Parkinson's Disease Patients' Preferences for Communication About Advanced Care Planning Keiran Tuck, MD
03:00 PM - 06:30 PM	Abstract	305 - Mindfulness-Based Therapies in the Treatment of Somatization Disorders: A Meta-Analysis Shaheen E. Lakhan, MD, PhD, MEd, FAAN
03:00 PM - 06:30 PM	Abstract	306 - False localizing exam in a lumbar spinal epidural abscess (SEA): right paraspinal pain and contralateral leg weakness Pavis Laengvejkal, MD
03:00 PM - 06:30 PM	Abstract	307 - The PRIZM (Patient Registry of Intrathecal Ziconotide Management) Study for Patients With Severe Chronic Pain
03:00 PM - 06:30 PM	Abstract	308 - Relationship Between Pharmacokinetics And Urine Drug Screen For Opioids: A Method To Determine Efficacy, Safety And Abuse Fadi H. Delly, MD
03:00 PM - 06:30 PM	Abstract	309 - Persistent Na+ and K+ Channel Dysfunctions after Chronic Exposure to Insecticides and Pyridostigmine Bromide Nan Jiang, MD
03:00 PM - 06:30 PM	Abstract	310 - Pain Profiles in Small Fiber Neuropathy Maria Alejandra Gonzalez Duarte, MD, FAAN
03:00 PM - 06:30 PM	Abstract	311 - Contact Heat Evoked Potentials Stimulator (CHEPS) And Thermal Quantitative Sensory Testing (QST) In The Assement Of Atypical Orofacial Pain Bruno Coutinho, MD
03:00 PM - 06:30 PM	Abstract	312 - Shifts in Pain Severity Categories among Patients with Painful Diabetic Peripheral Neuropathy or Postherpetic Neuralgia Treated with Pregabalin B. Parsons
03:00 PM - 06:30 PM	Abstract	313 - Pharmacokinetics of DS-5565, a Novel ?2? Ligand, in Rats and Monkeys, and Assessment of DDI Risk Naotoshi Yamamura
03:00 PM - 06:30 PM	Abstract	314 - Suicide in a Woman Diagnosed with Bulbar Predominant Amyotrophic Lateral Sclerosis: A Case Report and Literature Review Maggie McNulty, MD
03:00 PM - 06:30 PM	Abstract	315 - Approaching The Mechanisms Underlying Analgesia Induced By High Voltage Electrical Stimulation Of Lumbosacral Nerve Roots Valter Troni, MD
03:00 PM - 06:30 PM	Abstract	316 - The Palliative Care Needs of Patients Living with Life-Limiting Neurological Illness Marvin C. Chum, MD
03:00 PM - 06:30 PM	Abstract	317 - Combined Supraorbital (SONS) and Occipital Nerve Stimulation (ONS) for Intractable Post-Herpetic Neuralgia Francis X. Conidi, DO, MS, FAHS, FAAN
03:00 PM - 06:30 PM	Abstract	318 - The Need for Early Recognition of Complex Regional Pain Syndrome to Facilitate Early Effective Treatment Jacquelyn Laplant
03:00 PM - 06:30 PM	Abstract	320 - A noninvasive neurotechnology, HIRREM, is associated with symptom reduction and improved cardiovascular autonomic measures in adolescents with POTS Catherine Tegeler
03:00 PM - 06:30 PM	Abstract	321 - A novel SUCLA2 mutation associated with a complex childhood movements disorder Caterina Garone
03:00 PM - 06:30 PM	Abstract	322 - An Unusual Presentation of Neuropathy Secondary to Leprosy (Hansen's disease) Derrece K. Reid, MD
03:00 PM - 06:30 PM	Abstract	323 - Increased Coherence between the Basal Ganglia and Motor Cortex in a Rat Model of Pediatric Asphyxial Cardiac Arrest. Bhooma R. Aravamuthan, MD, PhD
03:00 PM - 06:30 PM	Abstract	324 - Neuro-Developmental Disorders in India - From Epidemiology to Public Policy Donald H. Silberberg, MD, FAAN
03:00 PM - 06:30 PM	Abstract	325 - Rituximab therapy as a first-line immunosuppressive treatment in children with neuromyelitis optica spectrum disorder: a single-center experience. Giulia Longoni, MD
03:00 PM - 06:30 PM	Abstract	326 - Periventricularlaminar heterotopia (PLH): characterization in a series of 18 patients Dina R. Amrom, MD
03:00 PM - 06:30 PM	Abstract	327 - A case report of 4H syndrome probably caused by a heterozygous abnormality of the POLR3A gene with preserved intellectual function
03:00 PM - 06:30 PM	Abstract	328 - Sideroflexin-4 defects cause a new infantile mitochondrial disorder affecting hematopoietic and central nervous systems. Caterina Garone
03:00 PM - 06:30 PM	Abstract	329 - Intrinsic Excitability Defects in Specific Subtypes of Medial Prefrontal Cortex Pyramidal Neurons in a Mouse Model of Autism Audrey C. Brumback, MD, PhD
03:00 PM - 06:30 PM	Abstract	330 - A Comparison of Co-located and Traditional Outpatient Consultation for the Treatment of ADHD in Two Urban Medical Homes : Costs and Outcomes David K. Urion, MD, FAAN
03:00 PM - 06:30 PM	Abstract	331 - Ehlers-Danlos type IV presenting with a peroneal neuropathy Amitha Ananth, MD
03:00 PM - 06:30 PM	Abstract	332 - Patients with Electrical Status Epilepticus in Sleep and Normal Magnetic Resonance Imaging have Smaller Thalamic Volume than Controls Ivan Sanchez Fernandez, MD
03:00 PM - 06:30 PM	Abstract	333 - Brainstem Disconnection Syndrome in a Patient with Fetal Alcohol Syndrome Chandan B. Mehta, MD
03:00 PM - 06:30 PM	Abstract	334 - Cerebrospinal Fluid Opening Pressure in a Pediatric Demyelinating Disease Cohort Sona Narula, MD
03:00 PM - 06:30 PM	Abstract	335 - Soto-like syndrome and cortical malformation associated with chromosome 19p13.2 microdeletion including Nuclear Factor-1X (NFIX) Swati Karmarkar, MD
03:00 PM - 06:30 PM	Abstract	336 - Efficacy of EPA Enriched Phosphatidylserine-Omega-3 (Vayarin) on Children with ADHD Stephanie Nguyen
03:00 PM - 06:30 PM	Abstract	337 - Neurocognitive and Psychological Profiles of Children with Idiopathic Epilepsy Adel Eladl
03:00 PM - 06:30 PM	Abstract	338 - Multi-domain Neurodevelopmental Delays in Multiple Gestation and Singleton Preterm Infants Imad T. Jarjour, MD, FAAN
03:00 PM - 06:30 PM	Abstract	339 - Retrospective review of inpatient headache admissions: looking at determinants of a successful admission Arnold J. Sansevere, MD
03:00 PM - 06:30 PM	Abstract	340 - Resting state EEG serves as a promising biomarker of cognitive and language function in young children with ASD.
03:00 PM - 06:30 PM	Abstract	341 - Pathology of the Neurovascular Unit in Cerebral X-linked Adrenoleukodystrophy Sandra Jimenez, MD
03:00 PM - 06:30 PM	Abstract	342 - Cortical involvement in early and late stages of metachromatic leukodystrophy Jan-Mendelt Tillema, MD
03:00 PM - 06:30 PM	Abstract	343 - Stroke due to Extracranial Internal Carotid Artery Dissection after Roller Coaster Rides in a 4-year-old boy Amre Nouh, MD, FAAN
03:00 PM - 06:30 PM	Abstract	344 - Video EEG Monitoring in Infants: Predictors of Subclinical Seizures in the ICU Setting Eileen Broomall, MD
03:00 PM - 06:30 PM	Abstract	345 - Case Study with Video Clips: Midbrain Dysfunction and Restoration in a 30 Year-Old Woman with Hydrocephalus Sarah Mulukutla, MD, MPH, FAAN

Faculty Disclosures
Lisa Hobson-Webb, MD, FAAN	An immediate family member of Dr. Hobson-Webb has received personal compensation for serving as an employee of G1 Therapeutics. Dr. Hobson-Webb has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing. The institution of Dr. Hobson-Webb has received research support from Sanofi Genzyme.
Amy Gelfand, MD	Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Headache Society. The institution of an immediate family member of Dr. Gelfand has received research support from Roche/Genentech. The institution of an immediate family member of Dr. Gelfand has received research support from Vigil Neuroscience. The institution of Dr. Gelfand has received research support from UCSF Resource Allocation Program. The institution of an immediate family member of Dr. Gelfand has received research support from NIH/NINDS. The institution of an immediate family member of Dr. Gelfand has received research support from National MS Society. The institution of Dr. Gelfand has received research support from PCORI. Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received publishing royalties from a publication relating to health care. An immediate family member of Dr. Gelfand has received personal compensation in the range of $50,000-$99,999 for serving as a Expert Witness with United States Department of Health and Human Services, Vaccine Injury Compensation Program. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Headache Cooperative of the Pacific. Dr. Gelfand has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Taiwan Headache Society. An immediate family member of Dr. Gelfand has a non-compensated relationship as a Clinical Trial Steering Committee Member with Roche/Genentech that is relevant to AAN interests or activities.
Mark Hallett, MD, FAAN	Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Hallett has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainsway. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for VoxNeuro. Dr. Hallett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for QuantalX. Dr. Hallett has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hallett has received intellectual property interests from a discovery or technology relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received publishing royalties from a publication relating to health care. Dr. Hallett has received personal compensation in the range of $500-$4,999 for serving as a Speaker with International Parkinson and Movement Disorder Society. Dr. Hallett has a non-compensated relationship as a President, Past-president with International Federation of Clinical Neurophysiology that is relevant to AAN interests or activities. Dr. Hallett has a non-compensated relationship as a President, Past-President with Functional Neurological Disorder Society that is relevant to AAN interests or activities.
Alan C. Carver, MD	No disclosure on file
Alexis M. Dallara-Marsh, MD	No disclosure on file
John K. Fink, MD	No disclosure on file
	No disclosure on file
Alexandra Fuchs, MD	No disclosure on file
Vicki Shanker, MD, FAAN	Dr. Shanker has nothing to disclose.
Tobias Loddenkemper, MD, FAAN	No disclosure on file
Arthur H. Burghes, MD	No disclosure on file
Toshiki Fujioka, MD	Dr. Fujioka has nothing to disclose.
Fabrizio Salvi, MD	No disclosure on file
Fred D. Lublin, MD, FAAN	Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH.
Hannes Vogel, MD	Dr. Vogel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Lipton Law . Dr. Vogel has received publishing royalties from a publication relating to health care.
Zbigniew K. Wszolek, MD, FAAN	Dr. Wszolek has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Polish Neurological Society/Via Medica.
Steven L. Lewis, MD, FAAN	Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for American Board of Psychiatry and Neurology. Dr. Lewis has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Lewis has received publishing royalties from a publication relating to health care. Dr. Lewis has received publishing royalties from a publication relating to health care. Dr. Lewis has a non-compensated relationship as a Secretary General with World Federation of Neurology that is relevant to AAN interests or activities.
Brenda Banwell, MD, FAAN	Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Joseph Jankovic, MD, FAAN	Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Jankovic has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance, Allergan. The institution of Dr. Jankovic has received research support from Baylor College of Medicine. Dr. Jankovic has received research support from Abbvie. The institution of Dr. Jankovic has received research support from Abbvie.
Hubert H. Fernandez, MD, FAAN	Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevel. Dr. Fernandez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Fernandez has received research support from Biogen. The institution of Dr. Fernandez has received research support from Michael J Fox Founda. The institution of Dr. Fernandez has received research support from Roche. The institution of Dr. Fernandez has received research support from Parkinson Foundation. The institution of Dr. Fernandez has received research support from UCB. Dr. Fernandez has received publishing royalties from a publication relating to health care. Dr. Fernandez has received personal compensation in the range of $10,000-$49,999 for serving as a Steering Committee/Advisory Committee Member with Parkinson Study Group.
H. A. Jinnah, MD, PhD, FAAN	Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takaha/Ene. Dr. Jinnah has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Dr. Jinnah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. The institution of Dr. Jinnah has received research support from Addex. The institution of Dr. Jinnah has received research support from Aeon. The institution of Dr. Jinnah has received research support from Revance. The institution of Dr. Jinnah has received research support from Jazz.
Carlo Pozzilli	Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Mark Keegan, MD, FAAN	Dr. Keegan has received publishing royalties from a publication relating to health care.
Michele Tagliati, MD, FAAN	Dr. Tagliati has received publishing royalties from a publication relating to health care.
William B. Dobyns, MD	No disclosure on file
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. Dr. Lipton has stock in Axon. Dr. Lipton has stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Douglas L. Arnold, MD, FAAN	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has stock in NeuroRx.
David S. Goldstein, MD, PhD	Dr. Goldstein has received publishing royalties from a publication relating to health care.
Maria Alejandra Gonzalez Duarte, MD, FAAN	Dr. Gonzalez Duarte has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Gonzalez Duarte has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Gonzalez Duarte has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Anylam . The institution of Dr. Gonzalez Duarte has received research support from Pfizer.
Michael S. Leong	No disclosure on file
Robert J. Schwartzman, MD	No disclosure on file
Roy L. Freeman, MD	Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regenacy. Dr. Freeman has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurobo. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Freeman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Freeman has stock in Neurobo. Dr. Freeman has stock in Cutaneous NeuroDiagnostics. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck.
Douglas P. Larsen, MD	No disclosure on file
Mounzer Kassab, MD	No disclosure on file
Paul Matthews, MD	No disclosure on file
Marco Capobianco, MD	No disclosure on file
Tanya Simuni, MD, FAAN	Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cadia, AcureX, Adamas, AskBio, Amneal, Blue Rock Therapeutics, Caraway Therapeutics, Critical Path for Parkinson's Consortium (CPP), Denali, Michael J Fox Foundation, Neuroderm, Sanofi, Sinopia, Roche, Takeda and Vanqua Bio. Dr. Simuni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for of Koneksa, Neuroderm, Sanofi, UCB, AcureX, Adamas, AskBio, Biohaven, Denali, GAIN, Neuron23 and Roche. Dr. Simuni has received research support from Amneal, Biogen, Neuroderm, Prevail, Roche, and UCB and an investigator for NINDS, MJFF, Parkinson's Foundation.
Dean M. Wingerchuk, MD, FAAN	Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TTY Biopharm. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Reistone Biopharm. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Meyer Squibb. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Wingerchuk has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wingerchuk has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Wingerchuk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwers.
Nikolaus McFarland, MD, PhD, FAAN	Dr. McFarland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sutter Health. The institution of Dr. McFarland has received research support from NIH. Dr. McFarland has received publishing royalties from a publication relating to health care.
Gregory D. Cascino, MD, FAAN	Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Joel S. Perlmutter, MD, FAAN	Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for CHDI. Dr. Perlmutter has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Parkinson Study Group. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Wood, Cooper and Peterson, LLC . Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Simmons and Simmons LLP . The institution of Dr. Perlmutter has received research support from NIH. The institution of Dr. Perlmutter has received research support from American Parkinson Disease Association (Advanced Research Center at Washington University). The institution of Dr. Perlmutter has received research support from CHDI. The institution of Dr. Perlmutter has received research support from Huntington Disease Society of America. The institution of Dr. Perlmutter has received research support from University of Western Toronto. The institution of Dr. Perlmutter has received research support from Barnes-Jewish Hospital Foundation. The institution of Dr. Perlmutter has received research support from Michael J Fox Foundation. The institution of Dr. Perlmutter has received research support from UCSD. The institution of Dr. Perlmutter has received research support from Paula & Rodger Riney FUnd. The institution of Dr. Perlmutter has received research support from Jo Oertli Fund. The institution of Dr. Perlmutter has received research support from Murphy FUnd. The institution of Dr. Perlmutter has received research support from Fixel Fund. The institution of Dr. Perlmutter has received research support from N Grant WIlliams Fund. The institution of Dr. Perlmutter has received research support from Pohlman Fund. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a lecturer with Boston University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a external advisor with Stanford University. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with Beth Israel Hospital. Dr. Perlmutter has received personal compensation in the range of $500-$4,999 for serving as a visiting professor with U Pennsylvania.
Vahid Tohidi, MD, PhD	Dr. Tohidi has nothing to disclose.
Francoise Bouhour	No disclosure on file
Jonathan J. Eskenazi Markewitz, MD	No disclosure on file
David G. Lichter, FRACP, MBChB, FAAN	No disclosure on file
Aparna Wagle-Shukla, MD, FAAN	Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cavion. Dr. Wagle-Shukla has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Tremor research group. The institution of Dr. Wagle-Shukla has received research support from NIH. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
Oscar L. Lopez, MD, FAAN	Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck.
David E. Riley, MD	Dr. Riley has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Riley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen.
Paul G. Mathew, MD, FAHS, FAAN	Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CRICO.
Stephen G. Reich, MD, FAAN	Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Best Doctors. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UpToDate. Dr. Reich has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Reich has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. The institution of Dr. Reich has received research support from ninds. Dr. Reich has received publishing royalties from a publication relating to health care. Dr. Reich has received publishing royalties from a publication relating to health care.
Tahseen Mozaffar, MD, FAAN	Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/ Ra Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maze Therapeutics. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institutes of Health. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neuromuscular Disease Foundation. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi-Genzyme. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Spark Therapeutics. The institution of Dr. Mozaffar has received research support from Audentes Therapeutics. The institution of Dr. Mozaffar has received research support from Cartesian. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Laszlo Mechtler, MD, FASN, FAAN	Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Jushi Inc. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Mechtler has received stock or an ownership interest from Jushi Co.. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Amgen/Novartis. The institution of Dr. Mechtler has received research support from Alder/ Lundbeck. The institution of Dr. Mechtler has received research support from Abbvie/Allergan. The institution of Dr. Mechtler has received research support from Miles for Migraine. The institution of Dr. Mechtler has received research support from American Migraine Foundation. The institution of Dr. Mechtler has received research support from Charlotte's Web.
Michael S. Okun, MD, FAAN	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Shahram Khalid, MD	No disclosure on file
Antonio Toscano, MD	Dr. Toscano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme.
Nabila Dahodwala, MD, FAAN	Dr. Dahodwala has received personal compensation in the range of $0-$499 for serving as a Consultant for Genetech. Dr. Dahodwala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mediflix. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dahodwala has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Post and Schell. Dr. Dahodwala has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for O'Brien & Ryan, LLP. The institution of Dr. Dahodwala has received research support from AbbVie. The institution of Dr. Dahodwala has received research support from Medtronic.
William Ondo, MD	Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cerevel. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Ondo has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Ondo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACADIA. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Allergan. Dr. Ondo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyowa Kirin. The institution of Dr. Ondo has received research support from Cerevel. The institution of Dr. Ondo has received research support from Sun. The institution of Dr. Ondo has received research support from SCION. The institution of Dr. Ondo has received research support from Harmony. Dr. Ondo has received publishing royalties from a publication relating to health care.
Cynthia L. Comella, MD, FAAN	Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acorda Therapeutics. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck LTD. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Allergan Inc. Dr. Comella has received personal compensation in the range of $0-$499 for serving as a Consultant for Merz. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion. Dr. Comella has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Aeon. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceutical. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Michelle Monje, MD, PhD, FAAN	No disclosure on file
Lisa M. DeAngelis, MD, FAAN	Dr. DeAngelis has nothing to disclose.
David L. Bachman, MD	No disclosure on file
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Peter Przekop, DO, PhD	No disclosure on file
Emma Ciafaloni, MD, FAAN	Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Michael K. Hehir II, MD	Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Hehir has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Hehir has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Hehir has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Continuum- American Academy of Neurology. Dr. Hehir has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. The institution of Dr. Hehir has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. Hehir has received research support from University of Vermont Medical Center.
Jerry J. Shih, MD, FAAN	Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Shih has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurelis. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life. Dr. Shih has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Shih has received research support from Neurona. The institution of Dr. Shih has received research support from NCGS, Inc. Dr. Shih has a non-compensated relationship as a Test Writing Committee Member with ABPN that is relevant to AAN interests or activities.
Christian A. Rosado, MD, FAAN	No disclosure on file
Scott L. Silliman, MD	Dr. Silliman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Brian C. Healy	The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Merry Chen, MD	Dr. Chen has nothing to disclose.
Stephan Schuele, MD, FAAN	Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis. Dr. Schuele has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Jazz. Dr. Schuele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Schuele has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Thomas Needham. Dr. Schuele has received research support from National Institute of Health.
Kevin M. Flanigan, MD, FAAN	Dr. Flanigan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Apic Bio. Dr. Flanigan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AavantiBio. Dr. Flanigan has stock in 4D Molecular Therapeutics. The institution of Dr. Flanigan has received research support from Abeona Therapeutics. The institution of Dr. Flanigan has received research support from Sarepta Therapeutics. The institution of Dr. Flanigan has received research support from Astellas Therapeutics. Dr. Flanigan has received intellectual property interests from a discovery or technology relating to health care.
Osvaldo J. Nascimento, MD, PhD, FAAN	Dr. Nascimento has nothing to disclose.
A. M. Barrett, MD, FAAN	The institution of Dr. Barrett has received research support from Veterans Health Association. The institution of Dr. Barrett has received research support from National Institutes of Health. The institution of Dr. Barrett has received research support from Mabel H Flory Trust. Dr. Barrett has received personal compensation in the range of $0-$499 for serving as a author, chapter with WebMD.
Biljana Beretich, MD	No disclosure on file
Max R. Trenerry, PhD	No disclosure on file
Kelly D. Foote, MD	Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Robert A. Hauser, MD, MBA, FAAN	Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Global Kinetics Consulting (GKC). Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuroDerm. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scion Neurostim LLC. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sunovion Pharmaceuticals. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar Inc.. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Revance Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus Pharma. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inhibikase. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pharma 2 B. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivifi Biotech. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Therapeutics. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ovid Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AgeX Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanex. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MDCE Suzhou. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedRhythms. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PDNeurotechnology. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Regenxbio. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tremor Research Support Group. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tris Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acorda Therapeutics. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Ameal . Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine. Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sunovion. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Cerevel. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Inhibikase. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has stock in Inhibikase. Dr. Hauser has stock in Axial Therapeutics. Dr. Hauser has stock in Enterin. Dr. Hauser has stock in Revance Therapeutics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Artizan Biosciences. The institution of Dr. Hauser has received research support from Parkinsons & Movement Disorder Alliance. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Aeon Biopharma. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Bukwang Pharmaceutical Co., Ltd.. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Cynapsus Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Impax Labratories. The institution of Dr. Hauser has received research support from Integrative Research Labratories Sweden. The institution of Dr. Hauser has received research support from Lundbeck, Inc.. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuraly Inc.. The institution of Dr. Hauser has received research support from Neurocrine Biosciences. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Pharma Two B Ltd.. The institution of Dr. Hauser has received research support from Revance Therapeutics. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Sanofi Pharmaceuticals. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from SunPharma. The institution of Dr. Hauser has received research support from UCB BioPharma. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Maggie McNulty, MD	No disclosure on file
Stuart H. Isaacson, MD, FAAN	The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sunovion. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for acorda. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for adamas. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neuroderm. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. The institution of Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for adamas. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Isaacson has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie.
Alberto J. Espay, MD, FAAN	Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neuroderm. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acorda. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Herantis Pharma. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus (formerly USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaps Dx. Dr. Espay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AskBio. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus (formerly, USWorldMeds). Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. Dr. Espay has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Avion Pharmaceuticals. The institution of Dr. Espay has received research support from NIH. The institution of Dr. Espay has received research support from Michael J Fox Foundation for Parkinson's Research. Dr. Espay has received intellectual property interests from a discovery or technology relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care. Dr. Espay has received publishing royalties from a publication relating to health care.
Salvatore DiMauro, MD	No disclosure on file
Tanuja Chitnis, MD, FAAN	Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Siemens. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Academic CME. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche.
Imad T. Jarjour, MD, FAAN	No disclosure on file
Andrea Calvo, MD, PhD, FAAN	Dr. Calvo has nothing to disclose.
Simona Malucchi	No disclosure on file
Samer D. Tabbal, MD, FAAN	No disclosure on file
Emilien Delmont, MD	No disclosure on file
Benjamin L. Walter, MD	Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medtronic. Dr. Walter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Walter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbott.
Nicholas J. Silvestri, MD, FAAN	Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Regeneron. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Strongbridge. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for argenx. Dr. Silvestri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Silvestri has received publishing royalties from a publication relating to health care.
Nizar Souayah, MD, FAAN	Dr. Souayah has received publishing royalties from a publication relating to health care.
Wei Hu, MD, PhD	No disclosure on file
Bahareh Hassanzadeh, MD	Dr. Hassanzadeh has nothing to disclose.
Luca Durelli, MD	No disclosure on file
Jose E. Cavazos, MD, PhD	Dr. Cavazos has received stock or an ownership interest from Brain Sentinel . The institution of Dr. Cavazos has received research support from NIH.
John Corboy, MD, FAAN	Dr. Corboy has received personal compensation for serving as an employee of U of Coloado. Dr. Corboy has received personal compensation for serving as an employee of Rocky Mountain MS Center. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mylan. Dr. Corboy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squib. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Corboy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Corboy has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Mylan. The institution of Dr. Corboy has received research support from MedDay. The institution of Dr. Corboy has received research support from Novartis. The institution of Dr. Corboy has received research support from NMSS. The institution of Dr. Corboy has received research support from PCORI. The institution of Dr. Corboy has received research support from EMD Serono.
Thomas O. Crawford, MD	Dr. Crawford has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen.
B. Parsons	No disclosure on file
Yongjie Li	No disclosure on file
Gad M. Gilad, PhD	No disclosure on file
Kalina M. Sanders, MD	No disclosure on file
Edward J. Cupler, MD, FAAN	Dr. Cupler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Jonathan S. Katz, MD	Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Calico. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Griffols. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
P. D. Charles, MD, FAAN	Dr. Charles has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Newronika. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ipsen. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iota. Dr. Charles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Charles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Charles has stock in Arena Therapeutics. The institution of Dr. Charles has received research support from Pharma 2 B. The institution of Dr. Charles has received research support from Intec. The institution of Dr. Charles has received research support from Merz. The institution of Dr. Charles has received research support from Novartis. The institution of Dr. Charles has received research support from Aeon. The institution of Dr. Charles has received research support from Impax.
Darryl C. De Vivo, MD, FAAN	Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Jean P. Azulay, MD	Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for abbvie. Dr. Azulay has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Sylvia M. Lucas, MD, PhD	No disclosure on file
Muhammad F. Suri, MD	Dr. Suri has nothing to disclose.
Gregory Norris, MD	No disclosure on file
Gianna Carla Riccitelli	No disclosure on file
Jonathan L. Carter, MD	Dr. Carter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck Pharmaceuticals A/S. The institution of Dr. Carter has received research support from MedDay Pharmaceuticals . The institution of Dr. Carter has received research support from Roche Pharmaceuticals.
Kenneth M. Heilman, MD, FAAN	Dr. Heilman has received publishing royalties from a publication relating to health care.
Morvarid Karimi, MD	No disclosure on file
Shu Leong Ho, MD, FAAN	No disclosure on file
Pavel Klein, MD, FAAN	The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Aquestive. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Sience. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alliance. The institution of Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Arvelle Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Aquestive. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB Pharma. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sunovion. Dr. Klein has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PrevEp. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Fenwick . Dr. Klein has received research support from DOD/CURE.
Petra Schicklmaier, PhD	No disclosure on file
Todd D. Levine, MD	Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has stock in CND Life Sciences. Dr. Levine has stock in Corinthian reference lab.
John G. Nutt, MD, FAAN	No disclosure on file
Helen E. Stephens	No disclosure on file
Christine Tranchant, MD	No disclosure on file
Aubrey Adams, PhD	Dr. Manack Adams has received personal compensation for serving as an employee of Abbvie. Dr. Manack Adams has stock in Abbvie.
Harry B. Coslett, MD, FAAN	No disclosure on file
Gary S. Gronseth, MD, FAAN	Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Brain & Life. Dr. Gronseth has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Gronseth has received personal compensation in the range of $0-$499 for serving as a Member/EBM consultant Guideline Development Subcommittee with AAN.
Peter W. Kaplan, MBBS, FRCP, FAAN	Dr. Kaplan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for DNP Epiwatch. Dr. Kaplan has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for IFCN. Dr. Kaplan has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Kaplan has received publishing royalties from a publication relating to health care.
Pasquale Calabrese, PhD	Dr. Calabrese has nothing to disclose.
Mitchell F. Brin, MD, FAAN	Dr. Brin has received personal compensation for serving as an employee of Allergan. Dr. Brin has stock in Allergan.
William E. Klunk, MD, PhD	No disclosure on file
Marcelo E. Bigal, MD, PhD	No disclosure on file
Meghan C. Campbell, PhD	The institution of Meghan C. Campbell has received research support from NIH. The institution of Meghan C. Campbell has received research support from NIH. The institution of Meghan C. Campbell has received research support from McDonnell Center for Systems Neuroscience. The institution of Meghan C. Campbell has received research support from WUSM Radiology Department. The institution of Meghan C. Campbell has received research support from NIH. Meghan C. Campbell has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with Parkinson Foundation. Meghan C. Campbell has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Department of Defense.
Michael P. Macken, MD, MRCPI	Dr. Macken has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharma. Dr. Macken has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK LifeSciences. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hall Prangle Shonfeld. The institution of Dr. Macken has received research support from LivaNova.
Jan-Mendelt Tillema, MD	Dr. Tillema has nothing to disclose.
Cindy Zadikoff, MD	No disclosure on file
Ann Gruber-Baldini	No disclosure on file
Emmanuelle Le Page	Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK. Emmanuelle Le Page has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Brian S. Tseng, MD, PhD	No disclosure on file
Cristina M. Ramo, MD	Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANDOZ. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIOGEN. Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Dr. Ramo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Ramo has received research support from HORIZON-2020. The institution of Dr. Ramo has received research support from fis (SPANISH GOVERNMENT). The institution of Dr. Ramo has received research support from BIOGEN. The institution of Dr. Ramo has received research support from MERCK. The institution of Dr. Ramo has received research support from ALMIRALL. The institution of Dr. Ramo has received research support from NOVARTIS. The institution of Dr. Ramo has received research support from RICORS (Spanish Government). The institution of Dr. Ramo has received research support from ROCHE. Dr. Ramo has received publishing royalties from a publication relating to health care.
Rafael H. Llinas, MD, FAAN	Dr. Llinas has nothing to disclose.
Amy A. Pruitt, MD, FAAN	Dr. Pruitt has nothing to disclose.
David S. Saperstein, MD	No disclosure on file
Lara W. Katzin, MD	Dr. Katzin has nothing to disclose.
Rebecca F. Gottesman, MD	Dr. Gottesman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neurology. The institution of Dr. Gottesman has received research support from NIH.
Nils Henninger, MD, PhD, FANA	Dr. Henninger has stock in United Health. Dr. Henninger has stock in Novo Nordisk. Dr. Henninger has stock in Elli Lilly. Dr. Henninger has stock in Kenvue. The institution of Dr. Henninger has received research support from DoD. The institution of Dr. Henninger has received research support from NIH. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Verge Genomics. Dr. Henninger has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Myrobalan Inc.
J. R. Singleton, MD	Dr. Singleton has received research support from NIH.
Ludwig Kappos, MD, FAAN	The institution of Dr. Kappos has received research support from Bayer. The institution of Dr. Kappos has received research support from Biogen. The institution of Dr. Kappos has received research support from Genentech. The institution of Dr. Kappos has received research support from Genzyme. The institution of Dr. Kappos has received research support from Janssen. The institution of Dr. Kappos has received research support from Merck Serono. The institution of Dr. Kappos has received research support from Minoryx. The institution of Dr. Kappos has received research support from Novartis. The institution of Dr. Kappos has received research support from Roche. The institution of Dr. Kappos has received research support from Sanofi. The institution of Dr. Kappos has received research support from Santhera. The institution of Dr. Kappos has received research support from Swiss MS Society, Swiss National Research Foundation, European Union, Roche Research Foundation, Innosuisse. The institution of Dr. Kappos has received research support from Shionogi. The institution of Dr. Kappos has received research support from Japan Tobacco. The institution of Dr. Kappos has received research support from Auriga Vision AG. The institution of Dr. Kappos has received research support from EMD Serono. The institution of Dr. Kappos has received research support from Glaxo Smith Kline. The institution of Dr. Kappos has received research support from Wellmera AG. The institution of Dr. Kappos has received research support from Eli Lilly (Suisse) SA. The institution of Dr. Kappos has received research support from Bristol Myers Squibb. The institution of Dr. Kappos has received research support from Celltrion Inc. Dr. Kappos has received intellectual property interests from a discovery or technology relating to health care.
Laura Marsh, MD	No disclosure on file
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FiND. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for INMune. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage.
Robert N. Schwendimann, MD, FAAN	No disclosure on file
Antonio Bertolotto, MD, FAAN	Dr. Bertolotto has nothing to disclose.
Iris Katharina Penner, PhD	The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. The institution of Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Penner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Penner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene . Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Penner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck.
Heli Hunter, NP	No disclosure on file
Jerome J. Graber, MD, MPH, FAAN	Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Academy of Neurology. Dr. Graber has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Dickie McCamey Attorneys at Law. Dr. Graber has a non-compensated relationship as a Editorial Board member with Neuro-Oncology: Practice, published by Oxford that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Journal of Pain and Symptom Management that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors with American Society of Neuroimaging that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Board of Directors and Certification Exam Committee Member with United Council of Neurogical Subspecialties that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Question of the Day 'app' committee and NeuroSAE and Continuum with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Graber has a non-compensated relationship as a Editorial Board Member with Practical Neurology (BMC) that is relevant to AAN interests or activities.
Shelly D. Ozark, MD	Dr. Ozark has nothing to disclose.
Shafali Jeste, MD, FAAN	Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance.
Jiaying Zhang, MD	Dr. Zhang has nothing to disclose.
Nina Y. Riggins, MD, FAAN	Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Gerson Lehrman Group . Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal Pharmaceuticals. Dr. Riggins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NeurologyLive. The institution of Dr. Riggins has received research support from ElectroCore (GammaCore). The institution of Dr. Riggins has received research support from Miles for Migraine. The institution of Dr. Riggins has received research support from Eli Lilly. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has received publishing royalties from a publication relating to health care. Dr. Riggins has a non-compensated relationship as a PI on research study with TheraSpecs that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Advisory Board with NeurologyLive that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a Member of the Board with Miles for Migraine that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI in the study which used sphenocath device with Dolor Technologies that is relevant to AAN interests or activities. Dr. Riggins has a non-compensated relationship as a PI with Theranica that is relevant to AAN interests or activities.
Ramon Lugo, MD	No disclosure on file
Helmut Butzkueven, MD, MBBS	Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Wenzhuan He, MD	Dr. He has nothing to disclose.
Ahmet Hoke, MD, PhD, FAAN	Dr. Hoke has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Disarm. Dr. Hoke has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Hoke has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Clinical and Translational Neurology. Dr. Hoke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Burke and Thomas. Dr. Hoke has received stock or an ownership interest from Axoprotego Therapeutics. The institution of Dr. Hoke has received research support from NIH. The institution of Dr. Hoke has received research support from DOD. The institution of Dr. Hoke has received research support from Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. The institution of Dr. Hoke has received research support from Foundation for Peripheral Neuropathy. Dr. Hoke has received intellectual property interests from a discovery or technology relating to health care.
Andrew R. Pachner, MD	No disclosure on file
Jacqueline Montes, PT, EdD, NCS	Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Masa-Aki Higuchi, MD	No disclosure on file
Miguel Ulla, MD, PhD	No disclosure on file
Innocenzo Rainero, MD, PhD	No disclosure on file
Olga Waln, MD	Dr. Waln has nothing to disclose.
Hock Luen Teoh	No disclosure on file
Bijen Nazliel	No disclosure on file
Manuela Matta	No disclosure on file
John G. Whitesides	John G. Whitesides has received personal compensation for serving as an employee of UCB. John G. Whitesides has received stock or an ownership interest from UCB.
Agnes Kowalska, MD	Dr. Kowalska has nothing to disclose.
Veit U. Becker, MD	No disclosure on file
Nicolaos Sfikas	No disclosure on file
Sherron H. Kell, MD	No disclosure on file
Archana Hinduja, MD	Dr. Hinduja has nothing to disclose.
Chandan B. Mehta, MD	Dr. Mehta has nothing to disclose.
Anand V. Patel, MD	Dr. Patel has nothing to disclose.
Anmar Razak, MD	Dr. Razak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals.
Donald Grosset	Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Glasgow Memory Clinic. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Donald Grosset has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Britannia. Donald Grosset has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for GE Healthcare. The institution of Donald Grosset has received research support from Parkinson's UK. Donald Grosset has received personal compensation in the range of $10,000-$49,999 for serving as a Clinical Director Excellence Network with Parkinson's UK.
Antonio V. Salgado, MD	No disclosure on file
Jonathan J. Ong, MD	No disclosure on file
Martin Meier, MD	No disclosure on file
Richard A. Smith, MD	Dr. Smith has received personal compensation for serving as an employee of Center for Neurologic Study. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care.
Fernando Dangond, MD, FAAN	Dr. Dangond has received personal compensation in the range of $1,000,000+ for serving as a Head, Global Clinical Development (employee for 12 years) with EMD Serono.
Shreyansh Shah, MD	No disclosure on file
Ann F. Hsu, PhD, PharmD	No disclosure on file
Rachana Gandhi, MD	Dr. Gandhi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Gandhi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Gandhi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam pharma. The institution of Dr. Gandhi has received research support from Akcea Therapeutics. The institution of Dr. Gandhi has received research support from UCB.
Richard M. Green, MD, FAAN	No disclosure on file
Neetu Agashivala	No disclosure on file
Robert Hyde, PhD	Dr. Hyde has received personal compensation for serving as an employee of Biogen International GmbH . Dr. Hyde has received stock or an ownership interest from Biogen .
Yana Krutoshinskaya, MD	No disclosure on file
Paola Sandroni, MD, PhD, FAAN	Dr. Sandroni has nothing to disclose.
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bio. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck Serono. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astra Zeneca. Dr. Bermel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LabCorp. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Tanya N. Turan, MD, FAAN	Dr. Turan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer/Merck. Dr. Turan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gore Inc. Dr. Turan has received publishing royalties from a publication relating to health care. Dr. Turan has received publishing royalties from a publication relating to health care.
Adam Carpenter, MD	No disclosure on file
Adnan Safdar, MD	Dr. Safdar has nothing to disclose.
Colette G. Donaghy, MC MRCP	Colette G. Donaghy, MC MRCP has nothing to disclose.
Samuel F. Hunter, MD, PhD	The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbview. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMDSerono. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. The institution of Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Osmotica. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMDSerono. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Hunter has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Hunter has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Hunter has received research support from Biogen. The institution of Dr. Hunter has received research support from Abbvie. The institution of Dr. Hunter has received research support from Genentech/Roche. The institution of Dr. Hunter has received research support from Janssen. The institution of Dr. Hunter has received research support from Novartis. The institution of Dr. Hunter has received research support from Osmotica. The institution of Dr. Hunter has received research support from Sanofi. Dr. Hunter has received intellectual property interests from a discovery or technology relating to health care. Dr. Hunter has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with MS Views and News. Dr. Hunter has a non-compensated relationship as a CEO - Volunteer with NeuroNexes/Novel Pharmaceutics Institute that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Novartis Pharmaceuticals that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Osmotica that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing support with Mallinckrodt that is relevant to AAN interests or activities. Dr. Hunter has a non-compensated relationship as a Writing Support with Sanofi that is relevant to AAN interests or activities.
Jun Mu, MD, PhD	No disclosure on file
Michael Eller, MD	No disclosure on file
Anjan Chatterjee, MD, MPH, FAHS, FAAN	No disclosure on file
Robert P. Rubens, MD, MBA, FAAN	Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals.
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NexGen. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Worldwide Clinical Trials. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BD. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gossamer Bio. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Toleranzia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
William D. Arnold, MD	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for La Hoffmann Roche. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cadent Therapeutics . Dr. Arnold has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Arnold has received research support from NIH. The institution of Dr. Arnold has received research support from NMD Pharma. The institution of Dr. Arnold has received research support from Gilead Sciences. The institution of Dr. Arnold has received research support from CureSMA. Dr. Arnold has received intellectual property interests from a discovery or technology relating to health care.
Joohi Jimenez Shahed, MD	Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bracket Global LLC. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpha Omega. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for RegenXBio. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Praxis. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa Kirin. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BlueRock Therapeutics. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PhotoPharmics. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex. The institution of Dr. Jimenez Shahed has received research support from Michael J Fox Foundation. The institution of Dr. Jimenez Shahed has received research support from Amneal. The institution of Dr. Jimenez Shahed has received research support from Annovis. The institution of Dr. Jimenez Shahed has received research support from SAGE. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with Movement Disorders Society. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Faculty with American Academy of Neurology. Dr. Jimenez Shahed has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with Parkinson Foundation. Dr. Jimenez Shahed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant on Research Grant with Florida Atlantic University. Dr. Jimenez Shahed has received personal compensation in the range of $0-$499 for serving as a Speaker with Tourette Association of America. Dr. Jimenez Shahed has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with NACCME.
Ericka P. Greene, MD, FAAN	Dr. Greene has received personal compensation for serving as an employee of Argenx. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion, Inc. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylx. Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Greene has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis . Dr. Greene has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ABPN.
Barbara P. Karp, MD, FAAN	Dr. Karp has received personal compensation in the range of $500-$4,999 for serving as a Faculty for a course on chemodenervation with Catalyst Medical Education.
John F. Rothrock, MD	The institution of Dr. Rothrock has received research support from AbbVie.
Frank L. Silver, MD	Dr. Silver has nothing to disclose.
Gennaro Bussone	No disclosure on file
Eli Diamond, MD	Dr. Diamond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Day One Biopharmaceuticals. Dr. Diamond has received research support from Applebaum Foundation. Dr. Diamond has received research support from Frame Family Fund. Dr. Diamond has received research support from Joy Family West Foundation.
Anahita F. Deboo, MD	Dr. Deboo has nothing to disclose.
Yahya Celik, MD	No disclosure on file
Aaron Vinik	No disclosure on file
Neha Dangayach, MD, FAAN	Dr. Dangayach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jacob's Institute. Dr. Dangayach has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Dangayach has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association: SVIN journal. The institution of Dr. Dangayach has received research support from The Aneurysm and AVM Foundation. The institution of Dr. Dangayach has received research support from Neurosteer. Dr. Dangayach has received research support from Visionable. Dr. Dangayach has received publishing royalties from a publication relating to health care. Dr. Dangayach has received publishing royalties from a publication relating to health care.
Luisa Rojas, MD	No disclosure on file
Narupat Suanprasert	No disclosure on file
Shaheen E. Lakhan, MD, PhD, MEd, FAAN	Dr. Lakhan has received personal compensation for serving as an employee of Zogenix, Fern Health, Thriveworks, The Learning Corp, Click Therapeutics. Dr. Lakhan has received personal compensation in the range of $1,000,000+ for serving as a Consultant for Shaheen Lakhan, MD, PhD, LLC. Dr. Lakhan has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine, Fern Health, Lin Health. Dr. Lakhan has received personal compensation in the range of $500,000-$999,999 for serving as an officer or member of the Board of Directors for Click Therapeutics, SpineThera. Dr. Lakhan has stock in Zogenix, NeuroSport, Click Therapeutics, SpineThera.
Fernando L. Pagan, MD, FAAN	Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acorda. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Adamas. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Kyowa Kirin. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for US World Meds. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acorda. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Adamas. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amneal. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Pagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. Dr. Pagan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Parkinsonism and related Disorders. Dr. Pagan has stock in Keiferx. The institution of Dr. Pagan has received research support from US World Meds. The institution of Dr. Pagan has received research support from Novartis.
Vincenzo Brescia Morra, MD	Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TEVA. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALMIRALL. Dr. Brescia Morra has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MERK. Dr. Brescia Morra has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MERK. The institution of Dr. Brescia Morra has received research support from FISM. Dr. Brescia Morra has a non-compensated relationship as a PI with FISM that is relevant to AAN interests or activities.
Lorenzo Pinessi, MD	No disclosure on file
Maurizio Moggio, MD	No disclosure on file
Robert L. Carruthers, MD	Dr. Carruthers has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Carruthers has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche and Genentech. The institution of Dr. Carruthers has received research support from Roche and Genentech .
Rosa M. Valerio, PhD	No disclosure on file
Salim Abboud	No disclosure on file
Matthew Grantz, MD	No disclosure on file
Olivier Outteryck	Olivier Outteryck has nothing to disclose.
Dalia Rotstein, MD	Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen/Horizon . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Aventis. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Rotstein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Dr. Rotstein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Rotstein has received research support from MS Canada. The institution of Dr. Rotstein has received research support from CMSC. The institution of Dr. Rotstein has received research support from Roche Canada. Dr. Rotstein has received research support from National MS Society.
Luca Prosperini, MD	No disclosure on file
Adrienne Boire, MD, PhD, FAAN	Dr. Boire has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apelis Pharmaceuticals. The institution of Dr. Boire has received research support from National Cancer Institute. The institution of Dr. Boire has received research support from Center for Experimental Therapeutics. The institution of Dr. Boire has received research support from STARR Cancer Consortium. The institution of Dr. Boire has received research support from National Cancer Institute. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care. Dr. Boire has received intellectual property interests from a discovery or technology relating to health care.
Hesham A. Abboud, MD	Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. The institution of Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alpine Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cycle Pharma. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axonics. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Abboud has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion . Dr. Abboud has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Abboud has received research support from Genentech . The institution of Dr. Abboud has received research support from Novartis. The institution of Dr. Abboud has received research support from BMS. The institution of Dr. Abboud has received research support from Sanofi-Genzyme. The institution of Dr. Abboud has received research support from The Guthy-Jackson Charitable Foundation. Dr. Abboud has received publishing royalties from a publication relating to health care.
Raymond C. Seet, MD	Dr. Seet has nothing to disclose.
Xiangyi Meng, PhD	Dr. Meng has nothing to disclose.
David J. Hewitt, MD	No disclosure on file
Tony W. Ho, MD	No disclosure on file
Erik P. Pioro, MD, DPhil, FAAN	Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Sandra D'Alfonso	No disclosure on file
Gary L. Pattee, MD	The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA pharmaceuticals. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA pharmaceiticals. The institution of Dr. Pattee has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for General Dynamics US military. The institution of Dr. Pattee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka pharmaceuticals.
Faisal A. Alsallom, MD	Dr. Alsallom has nothing to disclose.
Clotilde Balucani, MD, PhD	Dr. Balucani has nothing to disclose.
Andrew H. Chan, MD	No disclosure on file
Andrew Y. Robinson, MD	No disclosure on file
Vijayakumar Javalkar, MD, FAAN	Dr. Javalkar has nothing to disclose.
Fabio Pellegrini	Fabio Pellegrini has received personal compensation for serving as an employee of Biogen. Fabio Pellegrini has received stock or an ownership interest from Biogen.
Debra L. Byler, MD	No disclosure on file
Juergen Koehler, MD	No disclosure on file
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Donald H. Silberberg, MD, FAAN	No disclosure on file
Jens Volkmann, MD	No disclosure on file
Alexander P. Auchus, MD, FAAN	Dr. Auchus has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various law firms. Dr. Auchus has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms.
Jaya R. Trivedi, MD, FAAN	Dr. Trivedi has nothing to disclose.
Daniel Kantor, MD, FAAN	Dr. Kantor has received personal compensation for serving as an employee of Gateway Institute for Brain Research. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CorEvitas, LLC. The institution of Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Osmotica Pharmaceuticals. The institution of Dr. Kantor has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Kantor has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kantor has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. The institution of Dr. Kantor has received research support from Bristol Myers Squibb. Dr. Kantor has a non-compensated relationship as a HAP with MSFous (MSF) that is relevant to AAN interests or activities. Dr. Kantor has a non-compensated relationship as a Medical Board with MS Views & News that is relevant to AAN interests or activities.
Mark Stacy, MD	No disclosure on file
Andrew Riddehough	No disclosure on file
Ivan Garza, MD, FAAN	No disclosure on file
Carrie E. Robertson, MD, FAAN	Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Impel NeuroPharma. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LInpharma. Dr. Robertson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Satsuma. Dr. Robertson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Robertson has received research support from Lundbeck. The institution of Dr. Robertson has received research support from Biohaven. The institution of Dr. Robertson has received research support from Teva. Dr. Robertson has received publishing royalties from a publication relating to health care.
Susan C. Byrne, MD	No disclosure on file
Sven G. Meuth	Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. Sven G. Meuth has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Almirall. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA. Sven G. Meuth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Jacob S. Elkins, MD	No disclosure on file
Simon Faissner	Simon Faissner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Simon Faissner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Simon Faissner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Simon Faissner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Simon Faissner has received research support from DMSG. The institution of Simon Faissner has received research support from Novartis. The institution of Simon Faissner has received research support from Lead Discovery.
Chiara Briani, MD	Dr. Briani has nothing to disclose.
Pezhman Roohani, MD	No disclosure on file
Syed I. Hussain, MD	Dr. Hussain has nothing to disclose.
Seemant Chaturvedi, MD, FAHA, FAAN	Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Chaturvedi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Calgary. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Ramar & Paradiso. Dr. Chaturvedi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Cole, Scott, Kissane. The institution of Dr. Chaturvedi has received research support from NINDS.
Helene Zephir	Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
David R. Beers, PhD	No disclosure on file
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Camila Pupe, MD	Dr. Pupe has nothing to disclose.
Alzira A. Carvalho, MD	No disclosure on file
Sachin Agarwal, MD, MPH	Dr. Agarwal has nothing to disclose.
Codrin I. Lungu, MD, FAAN	Dr. Lungu has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier, inc..
Michelle A. Ferreira, DO	No disclosure on file
John-Michael Li, MD	No disclosure on file
Audrey Strongosky	No disclosure on file
Saugat Dey, MD	No disclosure on file
Roberta Lanzillo	Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Luiz H. Castro, MD	Dr. Castro has nothing to disclose.
Raymond T. Cheung, MD, FAAN	No disclosure on file
Dae-Il Chang, MD	No disclosure on file
Christopher Fanale, MD	No disclosure on file
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Madhu Soni, MD, FAAN	Dr. Soni has nothing to disclose.
Natividad Stover, MD	Dr. Stover has nothing to disclose.
Dhimant Dani, MD	Dr. Dani has nothing to disclose.
Arnold J. Sansevere, MD	Dr. Sansevere has nothing to disclose.
Makoto Yoneda	No disclosure on file
John Ratchford, MD	Dr. Ratchford has received personal compensation for serving as an employee of Genentech. Dr. Ratchford has stock in F. Hoffman La-Roche.
Peter Y. Van Den Bergh, MD, PhD, FAAN	Dr. Van den Bergh has nothing to disclose.
Stefan Bittner	Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Biogen Idec. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Merck Healthcare. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Novartis. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Roche. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Sanofi. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Bristol-Meyer-Squibbs. Stefan Bittner has received personal compensation in the range of $500-$4,999 for serving as a Honoria with Teva.
Mohit Bhatt	No disclosure on file
Sonya U. Steele, MD	No disclosure on file
Rania A. Elenein, MD	Dr. Elenein has nothing to disclose.
Srivadee Oravivattanakul, MD	Dr. Oravivattanakul has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva.
Ildefonso Rodriguez-Leyva, MD, PhD, FAAN	Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Laboratorios Carnot. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly Eli and Company. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Torrent Pharmaceuticals Mexico. Dr. Rodriguez-Leyva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for abbvie allergan.
Irene R. Boniece, MD	No disclosure on file
Karen M. Weidenheim, MD	No disclosure on file
Kenneth Wolski, MD	No disclosure on file
Susan A. Eaton, PharmD	No disclosure on file
Inhyup Kim, MD	No disclosure on file
Sahawat Tantikittichaikul, MD	No disclosure on file
Cameron Davis, MS	No disclosure on file
Freek Verheul, MD	No disclosure on file
Katherine A. Riester, MPH	No disclosure on file
Hamza I. Maqsood, MD	Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
Xiaojun You, PhD	No disclosure on file
Steven Levine, MD, FAHA	Dr. Levine has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MEDLINK. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Law Firms. The institution of Dr. Levine has received research support from NIH.
Janet Benesh, BSMT	No disclosure on file
Valter Troni, MD	No disclosure on file
Rodolfo C. Callejas-Rojas, MD	No disclosure on file
Niklas Bergvall	No disclosure on file
John DeToledo, MD	No disclosure on file
Brett A. Parker, MD	No disclosure on file
Peter Goadsby, MD, PhD, FRS	Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli-Lilly. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aurene. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Goadsby has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CoolTech LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PureTech Health LLC. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vial. Dr. Goadsby has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon Biopharma. Dr. Goadsby has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society. The institution of Dr. Goadsby has received research support from NIHR. The institution of Dr. Goadsby has received research support from Kallyope. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has received publishing royalties from a publication relating to health care. Dr. Goadsby has a non-compensated relationship as a Trustee with Migraine Trust that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Trustee with Organisation for Understanding Cluster Headache (UK) that is relevant to AAN interests or activities. Dr. Goadsby has a non-compensated relationship as a Executive roles with American Headache Society that is relevant to AAN interests or activities.
A. Gordon Smith, MD, FAAN	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merz. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US Department of Justice. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eidos. Dr. Smith has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Lexicon. Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. The institution of Dr. Smith has received research support from NIH (NINDS, NIDDK). Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $0-$499 for serving as a Study Section with NIH.
Franck Durif, MD, PhD	No disclosure on file
Fabrizio Stocchi	Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bial, Biogen, Sunovion, Lundbeck, UCB, Zambon, Chiesi, Lusofarmaco, Abbvie, Neuroderm, Kyowa, Synegile, Roche, Britannia, Sunovion, Blue Rock. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL, Zambon, Biogen, Roche, Synegile, Sunovion. Fabrizio Stocchi has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial, Zambon, UCB, Kyowa, Sunovion.
Guojun Zhao, MD	No disclosure on file
Aven W. Ford, MD	No disclosure on file
Rocio Hernandez Clares, MD, PhD	No disclosure on file
Benjamin R. Brooks, MD, FAAN	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Muscular Dystrophy Association. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with American Academy of Neurology that is relevant to AAN interests or activities.
Bjorn K. Sperling, MD	No disclosure on file
Stephan A. Mayer, MD	Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Braincool. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MaxQ AI. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Phagenesis. Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Mayer has received stock or an ownership interest from Neuroptics. Dr. Mayer has received publishing royalties from a publication relating to health care.
Andres M. Lozano, MD	Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insightec. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Lozano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Functional Neuromodulation.
Andrew M. Naidech, MD, FAAN	No disclosure on file
Bart Demaerschalk, MD, MSc, FRCPC, FAAN	Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Demaerschalk has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Demaerschalk has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The Neurologist . The institution of Dr. Demaerschalk has received research support from NICHD.
Philipp Albrecht, PhD	No disclosure on file
Michael Dobbs, MD	Dr. Dobbs has received publishing royalties from a publication relating to health care.
Daniel H. Selchen, MD	Dr. Selchen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Selchen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Selchen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Selchen has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva.
Danielle M. Andrade, MD	Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zodiac. Dr. Andrade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoke therapeutics. Dr. Andrade has received publishing royalties from a publication relating to health care. Dr. Andrade has a non-compensated relationship as a Chair of task force on Transition with International League Against Epilepsy that is relevant to AAN interests or activities.
Daniel Martinez-Ramirez, MD	Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Mexico. Dr. Martinez-Ramirez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott Mexico.
Robert G. Smith, MD, PhD	Dr. Smith has nothing to disclose.
Ivan Sanchez Fernandez, MD	No disclosure on file
Dominic Marchese, PharmD, RPh	No disclosure on file
Nestor Galvez-Jimenez, MD	Dr. Galvez-Jimenez has nothing to disclose.
Tunde Csepany, MD	Dr. Csepany has nothing to disclose.
Geertrui F. Vanhove, MD, PhD, MBA	No disclosure on file
Alla Borisovna Guekht, PhD	The institution of Prof. Guekht has received research support from Russian Science Foundation .
Hidehiko Okazawa, MD, PhD	No disclosure on file
Giulia Longoni, MD	Dr. Longoni has nothing to disclose.
Gianfranco Costantino, MD	No disclosure on file
Tania Kuempfel, MD	Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Pharma. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Wazim Mohamed, MD	Dr. Mohamed has nothing to disclose.
Vesper F. Ramos, MD	No disclosure on file
Robert H. Brown, Jr., MD, DPhil	Dr. Brown has received personal compensation for serving as an employee of ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Warren Alpert Foundation. Dr. Brown has received stock or an ownership interest from ApicBio. Dr. Brown has received stock or an ownership interest from Amylx. Dr. Brown has received stock or an ownership interest from Imstar. The institution of Dr. Brown has received research support from Angel Fund for ALS Research. The institution of Dr. Brown has received research support from ALS Association. The institution of Dr. Brown has received research support from ALSOne. The institution of Dr. Brown has received research support from NINDS. The institution of Dr. Brown has received research support from ALS Finding A Cure. Dr. Brown has received publishing royalties from a publication relating to health care.
Iscia Lopes-Cendes, MD, PhD	No disclosure on file
Francesca Vitetta, MD	No disclosure on file
Sylvie Gosselin, MD	No disclosure on file
Krisztina Bencsik, MD	No disclosure on file
Tomoko Takeda, MD	No disclosure on file
Paola Pergami, MD, PhD	No disclosure on file
Randi Hagerman	Randi Hagerman has received publishing royalties from a publication relating to health care.
Jinsy Andrews, MD, FAAN	Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as a Consultant for Cytokinetics. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revalasio . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AL-S Pharma. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quralis . Dr. Andrews has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Neurosense. Dr. Andrews has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Akava. The institution of Dr. Andrews has received research support from Amylyx. The institution of Dr. Andrews has received research support from Biogen . The institution of Dr. Andrews has received research support from Cytokinetics . The institution of Dr. Andrews has received research support from NIH . The institution of Dr. Andrews has received research support from Biohaven/Platform Trial. The institution of Dr. Andrews has received research support from Clene/Platform Trial . The institution of Dr. Andrews has received research support from Ra Pharma/Platform Trial . The institution of Dr. Andrews has received research support from Prilenia/Platform Trial . Dr. Andrews has received research support from ALS Association . Dr. Andrews has a non-compensated relationship as a Board of Trustee Member with ALS Association that is relevant to AAN interests or activities.
Sona Narula, MD	Dr. Narula has received personal compensation in the range of $0-$499 for serving as a Consultant for Medscape .
Douglas J. Gelb, MD, PhD, FAAN	Dr. Gelb has received publishing royalties from a publication relating to health care. Dr. Gelb has received publishing royalties from a publication relating to health care. Dr. Gelb has received publishing royalties from a publication relating to health care. Dr. Gelb has received personal compensation in the range of $500-$4,999 for serving as a multiple choice question writer for Continuum with AAN.
Raymond P. Roos, MD, FAAN	Dr. Roos has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink. Dr. Roos has stock in Amazon. Dr. Roos has stock in Amgen. Dr. Roos has stock in Apple. Dr. Roos has stock in Cigna. Dr. Roos has stock in IBM. Dr. Roos has stock in Ionis. Dr. Roos has stock in Pfizer. Dr. Roos has received research support from Lohengrin Foundation.
Ari Green, MD	Dr. Green has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline Therapeutics. Dr. Green has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bionure. Dr. Green has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Green has received research support from NINDS. The institution of Dr. Green has received research support from NMSS. The institution of Dr. Green has received research support from NIA. The institution of Dr. Green has received research support from Adelson Research Foundation. Dr. Green has received intellectual property interests from a discovery or technology relating to health care. Dr. Green has received personal compensation in the range of $500-$4,999 for serving as a Study Section with NINDS. Dr. Green has a non-compensated relationship as a Author with Viela Bio that is relevant to AAN interests or activities.
Jun Li, MD, PhD, FAAN	The institution of Dr. Li has received personal compensation in the range of $500-$4,999 for serving as a Consultant for FDA. The institution of Dr. Li has received research support from NIH. Dr. Li has a non-compensated relationship as a Associate Editor of ACTN journal with ANA that is relevant to AAN interests or activities.
Stefania Battistini, MD	No disclosure on file
Sayyed Sohrab, MD	No disclosure on file
Orla Hardiman, MD, FRCP, FAAN	Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Maria E. Alexianu, MD, PhD	No disclosure on file
Shibeshih Belachew, MD	Dr. Belachew has received personal compensation for serving as an employee of Biogen Inc. Dr. Belachew has received stock or an ownership interest from Biogen Inc.
Soe S. Mar, MD, FAAN	The institution of Dr. Mar has received research support from NIH.
Naheed L. Khan, MD, PhD, FRCP	No disclosure on file
Laila K. Jarjour, MB ChB MPH	No disclosure on file
Timothy E. Lotze, MD, FAAN	Dr. Lotze has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Department of Justice VICP. The institution of Dr. Lotze has received research support from NIH. The institution of Dr. Lotze has received research support from National MS Society. The institution of Dr. Lotze has received research support from Sarepta Therapeutics. The institution of Dr. Lotze has received research support from PTC THERAPEUTICS. The institution of Dr. Lotze has received research support from Avexis. Dr. Lotze has received publishing royalties from a publication relating to health care.
Olga Ciccarelli, MD, PhD, FRCP	Prof. Ciccarelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Prof. Ciccarelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Roberta J. Seidman, MD	Dr. Seidman has nothing to disclose.
Allison Przekop, DO	No disclosure on file
Bjorn Ambrosius	No disclosure on file
Suneel K. Gupta, PhD	No disclosure on file
Olivier Rascol, MD, PhD	Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie, Acorda, Aguettant, Alkahest, AlzProtect, Apopharma, Astrazeneca, Axovant, Bial, Biogen, Britannia, Buckwang, Centogene, Cerevel, Clevexel, Contera, GE Healthcare, Handltherapeutic, Ionis, Irlab, Jazz, Kyowa, LGD Nuvamid, Lundbeck, Merck, Merz, MundiPharma, Neuralight, Neuratris, Neuroderm, Novartis, ONO Pharma, Orion Pharma, Osmotica, Oxford Biomedica, Parexel, PD Neurotechnology, Pfizer, Polycaps, Prexton, Roche Therapeutics, Sanofi, Scienture, Servier,Sombiotech, Sunovion, Supernus, Synagile, Thelonius Mind, Takeda, Théranexus, Teva, Tools4patient, UCB, Vision 2 voice, XenoPort, XO, Zambon . Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BIAL. Dr. Rascol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MEDIZIN ACADEMY. The institution of Dr. Rascol has received research support from Agence Nationale de la Recherche (ANR), CHU de Toulouse, France-Parkinson, INSERM-DHOS Recherche Clinique Translationnelle, MJFox Foundation, Programme Hospitalier de Recherche Clinique, European Commission (FP7, H2020).
Santosh B. Murthy, MD	Dr. Murthy has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Stroke and Neurological disorders. The institution of Dr. Murthy has received research support from National Institutes of Health/NINDS.
Emily A. Woyshner, RPA-C	No disclosure on file
Bing Liao, MD	Dr. Liao has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for argenx .
Katharine Alter, MD	Katharine Alter, MD has received personal compensation for serving as an employee of Paradigm Medical Communications. Katharine Alter, MD has received personal compensation for serving as an employee of Cleveland clinic foundation. Katharine Alter, MD has received personal compensation for serving as an employee of Catalyst medical . Katharine Alter, MD has received personal compensation for serving as an employee of AANEM. Katharine Alter, MD has received personal compensation for serving as an employee of Efficiwent CME. Katharine Alter, MD has received publishing royalties from a publication relating to health care.
Massimo Filippi, MD, FAAN	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi;. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi- Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Catarina Quinzii Hirano, MD	No disclosure on file
Jurriaan Peters, MD	Dr. Peters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Peters has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Peters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis.
Pratik Bhattacharya, MD, MPH	Dr. Bhattacharya has a non-compensated relationship as a Research Advisor with Defeat MSA Alliance 501 (c) (3) that is relevant to AAN interests or activities.
Rachel P. Guimaraes, PT	No disclosure on file
Weining Robieson, PhD	Dr. Robieson has received personal compensation for serving as an employee of AbbVie. Dr. Robieson has received stock or an ownership interest from AbbVie.
Emanuele Barca, MD, PhD	Dr. Barca has nothing to disclose.
Emmanuelle Schindler, MD, PhD	The institution of Dr. Schindler has received research support from CH-TAC, LLC. The institution of Dr. Schindler has received research support from Wallace Research Foundation.
Aurora Fuiani, MD	No disclosure on file
Louis Royer-Perron, MD	No disclosure on file
Peii Chen	No disclosure on file
Pichet Termsarasab, MD	No disclosure on file
Maria Diaz Lorente, MD	No disclosure on file
Florian Eichler, MD	An immediate family member of Dr. Eichler has received personal compensation for serving as an employee of UpToDate. Dr. Eichler has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for SwanBio Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Eichler has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Origin Biosciences. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orchard Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Autobahn Therapeutics. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bluebird Bio. Dr. Eichler has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. Dr. Eichler has received stock or an ownership interest from SwanBio Therapeutics. The institution of Dr. Eichler has received research support from Bluebird Bio. The institution of Dr. Eichler has received research support from Minoryx Therpeutics. The institution of Dr. Eichler has received research support from Sio Therapeutics. Dr. Eichler has received intellectual property interests from a discovery or technology relating to health care.
Maria Trojano	Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Yves L. Lapierre, MD	No disclosure on file
Guy J. Buckle, MD	No disclosure on file
Bhaskar Roy, MD, FAAN	Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for argenx. Dr. Roy has stock in Cabaletta bio. . The institution of Dr. Roy has received research support from Martin Shubik Fund for IBM at Yale University. The institution of Dr. Roy has received research support from Abcuro Pharmaceuticals. The institution of Dr. Roy has received research support from Immunovant.
Alexander Sherman	The institution of Mr. Sherman has received research support from The ALS Association. The institution of Mr. Sherman has received research support from NIH. The institution of Mr. Sherman has received research support from FDA. The institution of Mr. Sherman has received research support from Biogen. The institution of Mr. Sherman has received research support from Amylyx Pharmaceuticals. The institution of Mr. Sherman has received research support from Mitsubishi-Tanabe Pharma America. Mr. Sherman has a non-compensated relationship as a Member, Board of Directors with ALD Connect that is relevant to AAN interests or activities.
Sandra L. Cook, RN	No disclosure on file
Jose Biller, MD, FACP, FAHA, FAAN	Dr. Biller has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer. Dr. Biller has received publishing royalties from a publication relating to health care.
Ping Zhuang, PhD	Dr. Zhuang has nothing to disclose.
Joseph Hentz	No disclosure on file
Jorina Elbers, MD	No disclosure on file
Jeffrey Rosenfeld, MD, PhD, FAAN	Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ML Biosolutions. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amylyx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catalyst. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anelixis. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroSense. Dr. Rosenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for MT Pharma America. Dr. Rosenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Strongbridge Pharma. Dr. Rosenfeld has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amylyx. The institution of Dr. Rosenfeld has received research support from MT Pharma. The institution of Dr. Rosenfeld has received research support from Alexion. The institution of Dr. Rosenfeld has received research support from Healey ALS Trial Center Mass General.
Francois Dubeau, MD	Dr. Dubeau has nothing to disclose.
Frederik Barkhof, MD, PhD	Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Frederik Barkhof has received personal compensation in the range of $0-$499 for serving as a Consultant for Biogen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Combinostics. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IXICO. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Frederik Barkhof has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EISAI.
David Uzenot, MD	No disclosure on file
Valerie A. Cwik, MD	No disclosure on file
Carolina Ionete, MD	Dr. Ionete has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from Biogen. The institution of Dr. Ionete has received research support from NIH.
Moses Rodriguez, MD, FAAN	Dr. Rodriguez has received intellectual property interests from a discovery or technology relating to health care.
Peter N. Riskind, MD, PhD	No disclosure on file
Audrey C. Brumback, MD, PhD	No disclosure on file
David H. Benninger, MD	No disclosure on file
Drini Dobi, MD, PhD	No disclosure on file
Marie-Pierre Chaunu	No disclosure on file
Christina L. Szperka, MD	The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Szperka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Upsher Smith. The institution of Dr. Szperka has received research support from NINDS. The institution of Dr. Szperka has received research support from PCORI. The institution of Dr. Szperka has received research support from International Headache Society.
Anna-Marieta Moise, MD	No disclosure on file
Eugene Y. Achi, MD	No disclosure on file
Jason R. Thonhoff, MD	Dr. Thonhoff has nothing to disclose.
David K. Urion, MD, FAAN	Dr. Urion has nothing to disclose.
Paolo Bellantonio, MD	No disclosure on file
Alaleh Raji, MD	No disclosure on file
Tarannum Khan, MD, MBBS, FAAN	Dr. Khan has nothing to disclose.
Krisztina Kovacs, MD	No disclosure on file
Caterina Garone	No disclosure on file
Richard M. Trosch, MD, FAAN	Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Amneal . Dr. Trosch has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurocrine . Dr. Trosch has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific.
Rocco Totaro, MD	No disclosure on file
Clemens Warnke	The institution of Clemens Warnke has received research support from Novartis. The institution of Clemens Warnke has received research support from Alexion. The institution of Clemens Warnke has received research support from Sanofi-Genzyme. The institution of Clemens Warnke has received research support from Biogen. The institution of Clemens Warnke has received research support from Roche.
Gerald Raymond, MD	Dr. Raymond has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Bluebird bio. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Raymond has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Travere. Dr. Raymond has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant with Dept of HHS.
Jared Medina, PhD	No disclosure on file
Bruno Coutinho, MD	No disclosure on file
Sung Hyuk Heo, MD	No disclosure on file
Xiang Fang, MD, PhD, FAAN	Dr. Fang has nothing to disclose.
Keith Van Haren, MD	Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viking Therapeutics. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bluebirdbio. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orpheris. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Van Haren has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME, Inc. The institution of Dr. Van Haren has received research support from Minoryx. The institution of Dr. Van Haren has received research support from bluebirdbio. Dr. Van Haren has a non-compensated relationship as a Board of Directors with ALD Connect that is relevant to AAN interests or activities. Dr. Van Haren has a non-compensated relationship as a Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to AAN interests or activities.
Thomas Dehmel	No disclosure on file
Stefania Corti, MD, PhD	Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Corti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
Philippe Truffinet, MD	Dr. Truffinet has received personal compensation for serving as an employee of Sanofi.
Terry D. Heiman-Patterson, MD	Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samus. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amylym. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics.
Björn Tackenberg, MD, FAAN	Dr. Tackenberg has received personal compensation for serving as an employee of F. Hoffmann-La Roche AG. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GILEAD. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Celgene. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tackenberg has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Tackenberg has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Merck Serono. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Tackenberg has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Tackenberg has received stock or an ownership interest from F. Hoffmann-La Roche AG. The institution of Dr. Tackenberg has received research support from Biogen. The institution of Dr. Tackenberg has received research support from Novartis. The institution of Dr. Tackenberg has received research support from Roche.
Damiano Baroncini	No disclosure on file
Slawomir Michalak, PhD	No disclosure on file
Martin Freed	No disclosure on file
Ching Hsu	No disclosure on file
Adriano Chio, MD, FAAN	Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen.
Susanna Usai	No disclosure on file
Shafeeq Ladha, MD	Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ladha has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Ladha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapa Therapeutics. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Ladha has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ladha has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Genentech. The institution of Dr. Ladha has received research support from Biogen. The institution of Dr. Ladha has received research support from Sanofi.
Carly Siskind, MS	No disclosure on file
Joseph F. Drazkowski, MD, FAAN	Dr. Drazkowski has nothing to disclose.
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expert Witness. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb.
Elson L. So, MD, FAAN	Dr. So has nothing to disclose.
Lola C. Morgan, MD	No disclosure on file
Irene L. Katzan, MD	Dr. Katzan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . The institution of Dr. Katzan has received research support from TEVA Pharmaceuticals.
Federica Agosta	Federica Agosta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philips. Federica Agosta has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier INC.
Yuki Hatanaka, MD	No disclosure on file
Timothy L. Vollmer, MD, FAAN	The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Calin I. Prodan, MD	The institution of Dr. Prodan has received research support from US Department of Veterans Affairs (Merit award CX000340).
Agnes Fromont	No disclosure on file
Fredy J. Revilla, MD, FAAN	Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TEVA . Dr. Revilla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA .
Victor C. Urrutia, MD	Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. The institution of Dr. Urrutia has received research support from Genentech, Inc. Dr. Urrutia has received personal compensation in the range of $5,000-$9,999 for serving as a Medical Director of CME course with PeerView.
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Jean-Christophe Antoine, MD	No disclosure on file
Yuen T. So, MD, PhD, FAAN	No disclosure on file
Curtis G. Benesch, MD, MPH	Dr. Benesch has nothing to disclose.
David B. Burkholder, MD, FAAN	The institution of Dr. Burkholder has received research support from Longboard pharmaceuticals.
John F. Foley, MD, FAAN	The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Foley has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics . The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. The institution of Dr. Foley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Foley has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Foley has stock in InterPRO Bioscience. The institution of Dr. Foley has received research support from Biogen. The institution of Dr. Foley has received research support from Novartis. The institution of Dr. Foley has received research support from Octave. The institution of Dr. Foley has received research support from Genentech. The institution of Dr. Foley has received research support from Imstem. The institution of Dr. Foley has received research support from Aegir.
Frederick Andermann, MD, FRCPC, FAAN	No disclosure on file
Eileen Broomall, MD	No disclosure on file
Muhammad Taimur A. Malik, MD	Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genetech . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jansen . Dr. Malik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD serono. The institution of Dr. Malik has received research support from National MS Society .
Christopher Perrone, MD	Dr. Perrone has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono.
Panayiotis Mitsias, MD	Dr. Mitsias has nothing to disclose.
Aakash N. Bodhit, MD	No disclosure on file
Massimiliano Copetti	No disclosure on file
Bryan T. Klassen, MD	The institution of Dr. Klassen has received research support from Insightec.
Sanjeev Sivakumar, MD	No disclosure on file
Peter S. Chin, MD	No disclosure on file
Gabriele Mora, MD	Dr. Mora has nothing to disclose.
Sheffali Gulati, MD, FAMS, FIAP, FIMS	Prof. Gulati has nothing to disclose.
James T. Boyd, MD	Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroDerm . Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for InTrance. Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Boyd has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Parkinson Study Group . The institution of Dr. Boyd has received research support from NIA/NIH. The institution of Dr. Boyd has received research support from Biotie . The institution of Dr. Boyd has received research support from vaccinex. The institution of Dr. Boyd has received research support from CHDI. The institution of Dr. Boyd has received research support from AbbVie. The institution of Dr. Boyd has received research support from Roche . The institution of Dr. Boyd has received research support from Revance . The institution of Dr. Boyd has received research support from NeuroDerm. The institution of Dr. Boyd has received research support from Neurocrine .
Malathi Rao, DO	Dr. Rao has nothing to disclose.
James J. Gugger, Jr., MD, PharmD	Dr. Gugger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ceribell. The institution of Dr. Gugger has received research support from American Epilepsy Society.
John Liang, MD	Dr. Liang has nothing to disclose.
Letizia Mazzini	No disclosure on file
Majaz Moonis, MD, FAHA, FAAN	No disclosure on file
Richard P. Goddeau, Jr., DO	No disclosure on file
Leonard L. Yeo, MBBS	The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrazeneca. The institution of Dr. Yeo has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for stryker. Dr. Yeo has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for NUHS. Dr. Yeo has received stock or an ownership interest from cereflo. The institution of Dr. Yeo has received research support from NMRC.
Yitzchok Lederman	No disclosure on file
Angelo Antonini, MD	Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
Nancy D. Rosales, MD	No disclosure on file
Alessia Di Sapio, MD	No disclosure on file
Anwar Ahmed, MD, FAAN	Dr. Ahmed has nothing to disclose.
Francois Grand-Maison, MD	Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis .
Christoph J. Schankin, MD	The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grünenthal. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Schankin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Schankin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Schankin has stock in Zynnon.
Sara A. Mayer, MD	No disclosure on file
Saqib A. Chaudhry, MD	Dr. Chaudhry has nothing to disclose.
Patrick M. Grogan, MD, FAAN	No disclosure on file
Argye E. Hillis, MD, MA	Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
Michio Hirano, MD, FAAN	Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Modis Therapeutics (a subsidiary of Zogenix). Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epirium Bio. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Innovation Specialist. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precision Biosciences. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Platform Q Health. Dr. Hirano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Hirano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stealth Biotherapeutics. The institution of Dr. Hirano has received research support from Modis Therapeutics (a subsidiary of Zogenix. The institution of Dr. Hirano has received research support from Cyclerion. Dr. Hirano has received research support from Reneo Pharmaceuticals. The institution of Dr. Hirano has received research support from Astellas. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received intellectual property interests from a discovery or technology relating to health care. Dr. Hirano has received personal compensation in the range of $0-$499 for serving as a Study Section Reviewer with NIH. Dr. Hirano has a non-compensated relationship as a Research Advisory Board member with Muscular Dystrophy Association that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific and Medical Advisory Board member with United Mitochondrial Disease Foundation that is relevant to AAN interests or activities. Dr. Hirano has a non-compensated relationship as a Scientific Advisory Board member with Barth Syndrome Foundation that is relevant to AAN interests or activities.
Shyam Prabhakaran, MD	Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. Dr. Prabhakaran has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Cincinnati. The institution of Dr. Prabhakaran has received research support from NIH . The institution of Dr. Prabhakaran has received research support from AHRQ. Dr. Prabhakaran has received publishing royalties from a publication relating to health care.
Christopher H. Gibbons, MD, FAAN	Dr. Gibbons has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience. Dr. Gibbons has stock in CND Life Sciences. Dr. Gibbons has received publishing royalties from a publication relating to health care. Dr. Gibbons has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Advisor with Department of Justice.
Gene Y. Sung, MD, MPH	The institution of Dr. Sung has received research support from NIH.
Richard L. Doty, PhD, FAAN	Dr. Doty has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Sensonics International. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for State of Kansas. Dr. Doty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Johnson & Johnson. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for McMahan Law Firm. Dr. Doty has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Offices of Walkup et al.. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ostroff Injury Law PC. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sacchett & Baldino. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Nebenzahl Law Group. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Ohio National Life Insurance Co. Dr. Doty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Tatum and Atkinson LLC. Dr. Doty has stock in Sensonics International. Dr. Doty has received publishing royalties from a publication relating to health care. Dr. Doty has received publishing royalties from a publication relating to health care. Dr. Doty has received publishing royalties from a publication relating to health care.
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Peter J. McAllister, MD, FAAN	Dr. McAllister has received personal compensation for serving as an employee of Revance. Dr. McAllister has received personal compensation for serving as an employee of AbbVie. Dr. McAllister has received personal compensation for serving as an employee of Merz. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aeon. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for lilly. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for teva. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for abbvie. Dr. McAllister has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for biohaven. Dr. McAllister has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for lundbeck.
Jennifer J. Majersik, MD, FAAN	Dr. Majersik has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Majersik has received research support from NIH/NINDS. The institution of Dr. Majersik has received research support from NIH/NCATS.
Raphael Hourez, MD, PhD	No disclosure on file
E. Ann Yeh, MD, MA, FRCPC	Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from Biogen. The institution of Dr. Yeh has received research support from Stem Cell Network. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from Ontario Institute for Regenerative Medicine. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from NIH. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from CMSC. The institution of Dr. Yeh has received research support from MSSC.
Fidias E. Leon-Sarmiento	No disclosure on file
Robert R. Coleman, MD	Dr. Coleman has nothing to disclose.
Alberto R. Martinez, MD	No disclosure on file
Dennys Reyes, MD	No disclosure on file
Kumar Rajamani, MD, FAAN	Dr. Rajamani has nothing to disclose.
Nobl Barazangi, MD, PhD	Dr. Barazangi has nothing to disclose.
David Gaist, MD	Dr. Gaist has nothing to disclose.
Wojciech Kozubski, MD, PhD	No disclosure on file
Paolo Ragonese	No disclosure on file
Daniel D. Truong, MD, FAAN	The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to AAN interests or activities.
Mark Groves, MD	No disclosure on file
Teneille Gofton, MD	The institution of Dr. Gofton has received research support from Government of Canada. The institution of Dr. Gofton has received research support from Canadian Institutes of Health Research. The institution of Dr. Gofton has received research support from Academic Medical Organisation of Southwestern Ontario. Dr. Gofton has a non-compensated relationship as a Medical Advisory Board Member with NORSE Institute that is relevant to AAN interests or activities.
David A. Roshal, DO	No disclosure on file
Jonathan D. Fridhandler, MD	No disclosure on file
Tjalf Ziemssen, MD, FAAN	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS Celgene. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. The institution of Dr. Ziemssen has received research support from Biogen. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from Celgene.
Ingo Kleiter	No disclosure on file
Anelyssa D'Abreu, MD, PhD, MPH	The institution of Dr. D'Abreu has received research support from Alzheimer's and Related Diseases Research Award Fund (Virginia Center on Aging in the College of Health Professions). The institution of Dr. D'Abreu has received research support from U.S. NIH Institute on Aging. The institution of Dr. D'Abreu has received research support from Biogen. The institution of Dr. D'Abreu has received research support from American College Of Radiology. The institution of Dr. D'Abreu has received research support from COGNITION THERAPEUTICS, INC.. Dr. D'Abreu has received personal compensation in the range of $500-$4,999 for serving as a Lecturer with Pri_med.
Dan J. Capampangan, MD, FAAN	No disclosure on file
John T. Slevin, MD, FAAN	Dr. Slevin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. The institution of Dr. Slevin has received research support from Veterans Administration. The institution of Dr. Slevin has received research support from NIH. The institution of Dr. Slevin has received research support from AbbVie. The institution of Dr. Slevin has received research support from NeuroDerm. The institution of Dr. Slevin has received research support from Bukwang-Syneos. The institution of Dr. Slevin has received research support from Takeda.
Jan Claassen, MD, PhD	Dr. Claassen has stock in iCE Neurosystems. The institution of Dr. Claassen has received research support from NINDS. The institution of Dr. Claassen has received research support from McDonnel Foundation. Dr. Claassen has received publishing royalties from a publication relating to health care. Dr. Claassen has received publishing royalties from a publication relating to health care.
Patricia Musolino, MD, PhD	Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx Pharmaceuticals. Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altas Venture Capital. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IONIS Pharmaceuticals . Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vertex. The institution of Dr. Musolino has received research support from National Institute of Health-NINDS-R01. The institution of Dr. Musolino has received research support from Angea Biotherapeutics. The institution of Dr. Musolino has received research support from Minoryx Pharmaceuticals. Dr. Musolino has received publishing royalties from a publication relating to health care.
Gian Marco De Marchis, MD	No disclosure on file
Masamichi Ikawa	No disclosure on file
Giuseppe Salemi, MD	No disclosure on file
Gary Birnbaum, MD, FAAN	No disclosure on file
Simon Warfield	No disclosure on file
Christopher Watling, MD	No disclosure on file
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INC research . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from TEVA.
Duarte G. Machado, MD	Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Kelvin L. Chou, MD, FAAN	Dr. Chou has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Chou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Miller & Wagner, LLP . The institution of Dr. Chou has received research support from NIH. The institution of Dr. Chou has received research support from Parkinson Study Group. The institution of Dr. Chou has received research support from Neuraly. The institution of Dr. Chou has received research support from Michael J Fox Foundation. Dr. Chou has received publishing royalties from a publication relating to health care. Dr. Chou has received publishing royalties from a publication relating to health care.
Jessica D. Lee, MD, FAAN	Dr. Lee has received personal compensation for serving as an employee of American Academy of Neurology.
Seon Hee Bu, MD	No disclosure on file
Shinsuke Fujioka, MD	Dr. Fujioka has received research support from Japan Society for the Promotion of Science.
Joachim Havla, MD	Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Havla has received research support from Merck.
Navid Seraji-Bozorgzad, MD	No disclosure on file
Gretchen A. Ayer, MS	No disclosure on file
Tobias Ruck	No disclosure on file
Giuliana Petri	No disclosure on file
Lisa R. Rogers, DO, FAAN	Dr. Rogers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure .
Leonardo Brito	No disclosure on file
Sarah Mulukutla, MD, MPH, FAAN	Dr. Mulukutla has received personal compensation in the range of $5,000-$9,999 for serving as a Meditation instructor & speaker with Weill Cornell Medicine.
Terrie Livingston, PharmD	Ms. Livingston has received personal compensation for serving as an employee of EMD Serono, Inc. Ms. Livingston has stock in EMD Serono, Inc. Ms. Livingston has stock in Biogen.
Jerry S. Wolinsky, MD, FAAN	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Virginia A. Devonshire, MD	No disclosure on file
Guangbin Xia, MD, PhD	No disclosure on file
Rick Magun, MD	Dr. Magun has nothing to disclose.
Marinella Clerico, MD	Dr. Clerico has nothing to disclose.
Mario Quarantelli, MD	No disclosure on file
Gary K. Lau, MBBS	Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boehringer Ingelheim. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Daiichi Sankyo. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizer. Dr. Lau has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Dr. Lau has received research support from Croucher Foundation. The institution of Dr. Lau has received research support from Research Fund Secretariat of the Food and Health Bureau, Hong Kong. The institution of Dr. Lau has received research support from Innovation and Technology Bureau, Hong Kong. The institution of Dr. Lau has received research support from Research Grants Council, Hong Kong. Dr. Lau has received publishing royalties from a publication relating to health care.
Sourabh Lahoti, MD	No disclosure on file
Eduardo R. Davidovich	Dr. Davidovich has nothing to disclose.
Juliana Gurgel-Giannetti	Juliana Gurgel-Giannetti has nothing to disclose.
Wenjuan Zhang, MD	No disclosure on file
Pamela Delgado	No disclosure on file
Rafael Escandon	No disclosure on file
Damiano Paolicelli	Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. Damiano Paolicelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Robert Hoepner	Robert Hoepner has nothing to disclose.
Francois Moreau, MD	No disclosure on file
Marvin C. Chum, MD	Dr. Chum has nothing to disclose.
William O. Tatum IV, DO, FAAN	Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Marc Chamberlain, MD	No disclosure on file
Ezgi Tiryaki, MD, FAAN	Dr. Tiryaki has received research support from University of Minnesota. The institution of Dr. Tiryaki has received research support from University of Minnesota.
Crystal T. Wong, MD	No disclosure on file
Judith Stephenson	No disclosure on file
Diego Cadavid, MD, FAAN	Dr. Cadavid has received personal compensation for serving as an employee of X4 Pharma. Dr. Cadavid has received personal compensation for serving as an employee of Fulcrum Therapeutics. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arvinas. Dr. Cadavid has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata Therapeutics. Dr. Cadavid has received stock or an ownership interest from X4 Pharma. Dr. Cadavid has received stock or an ownership interest from Fulcrum Therapeutics.
Alan Pestronk, MD, FAAN	The institution of Dr. Pestronk has received research support from RA. The institution of Dr. Pestronk has received research support from Fulcrum. The institution of Dr. Pestronk has received research support from Acceleron. The institution of Dr. Pestronk has received research support from Biogen. The institution of Dr. Pestronk has received research support from Jain. The institution of Dr. Pestronk has received research support from Sanofi. The institution of Dr. Pestronk has received research support from Muscular Dystrophy Association. Dr. Pestronk has received intellectual property interests from a discovery or technology relating to health care.
Jonathan D. Campbell, PhD	Dr. Campbell has received personal compensation for serving as an employee of Institute for Clinical and Economic Review.
Irene Malaty, MD, FAAN	Dr. Malaty has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Neuroderm. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a CME Speaker with Cleveland Clinic. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to AAN interests or activities.
Thierry Kuntzer, MD	No disclosure on file
John B. Williamson	No disclosure on file
Gregory A. Worrell, MD	Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.
Monika Mishra, MD	Dr. Mishra has nothing to disclose.
Zubair Ahmed, MD	Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Ahmed has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Ahmed has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven.
Greg M. Thaera, MD	No disclosure on file
Saeed A. Bohlega, MD	No disclosure on file
Nathalie Guy Renouil, MD	No disclosure on file
Lakshmi S. Amaravadi, PhD	No disclosure on file
Ahmad Riad Ramadan, MD	Dr. Ramadan has received publishing royalties from a publication relating to health care. Dr. Ramadan has received publishing royalties from a publication relating to health care.
Jamil R. Dibu, MD	No disclosure on file
Samuel Singer, MD	No disclosure on file
Lixin Zhang, MD, PhD	Dr. Zhang has nothing to disclose.
Karine Viala	No disclosure on file
Dina R. Amrom, MD	No disclosure on file
Arnaldo E. Velez, MD	No disclosure on file
Alexander M. Papanastassiou	Alexander M. Papanastassiou has received intellectual property interests from a discovery or technology relating to health care.
Sarah Louis Leonard	No disclosure on file
Babak S. Jahromi, MD, PhD, FRCSC	No disclosure on file
Michael L. Rosenberg, MD	Dr. Rosenberg has nothing to disclose.
Daniel Winkel, MD	The institution of Dr. Winkel has received research support from NextSense, Inc.
Karin Woodman, MD	Dr. Woodman has nothing to disclose.
Jera Kruja, MD	No disclosure on file
Octavian V. Lie, MD	No disclosure on file
Lisa Christopher-Stine, MD, MPH	No disclosure on file
Victor Chan, MD	No disclosure on file
Michal Gostkowski, DO	The institution of Dr. Gostkowski has received research support from Medtronic.
Christian Kamm, MD	No disclosure on file
Anna Mrelashvili, MD	No disclosure on file
Crystal Watson	Ms. Watson has received personal compensation for serving as an employee of Atara Biotherapeutics. Ms. Watson has received stock or an ownership interest from Atara Biotherapeutics.
David G. Wright, MD	Dr. Wright has nothing to disclose.
James D. Berry, MD MPH	Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene Nanomedicine. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma Holdings of America. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Berry has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berry has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Berry has stock in ReactNeuro. The institution of Dr. Berry has received research support from Biogen. The institution of Dr. Berry has received research support from MT Pharma of America. The institution of Dr. Berry has received research support from Rapa Therapeutics. The institution of Dr. Berry has received research support from Brainstorm Cell Therapeutics. The institution of Dr. Berry has received research support from Alexion. The institution of Dr. Berry has received research support from nQ Medical. The institution of Dr. Berry has received research support from ALSA. The institution of Dr. Berry has received research support from MDA. The institution of Dr. Berry has received research support from Amylyx. The institution of Dr. Berry has received research support from Transposon. Dr. Berry has a non-compensated relationship as a Scientific Advisor with Everything ALS that is relevant to AAN interests or activities.
Jean-Phillippe Camdessanche	Jean-Phillippe Camdessanche has nothing to disclose.
Birol Emir, PhD	No disclosure on file
Shivang Joshi, MD	Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lilly. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Currax. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Relivion. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nerivio. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axiome. Dr. Joshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven. Dr. Joshi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Joshi has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Joshi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Joshi has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Biohaven. The institution of Dr. Joshi has received research support from Lilly . The institution of Dr. Joshi has received research support from Biohaven. The institution of Dr. Joshi has received research support from Amgen.
Tigran Kesayan, MD	Dr. Kesayan has nothing to disclose.
Sonalee Agarwal, PhD	No disclosure on file
Kartik Raghupathi	No disclosure on file
James C. Grotta, MD, FAAN	Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Frazer Ltd. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Haemonetics. Dr. Grotta has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acticor. Dr. Grotta has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prolong Pharma. Dr. Grotta has received publishing royalties from a publication relating to health care. Dr. Grotta has received publishing royalties from a publication relating to health care.
Eva Andermann, MD, PhD	No disclosure on file
Charles A. Szabo, MD, FAAN	Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation of Central and South Texas. Dr. Szabo has received personal compensation in the range of $0-$499 for serving as a Reviewer with NINDS.
Emil G. Pedersen, MD	No disclosure on file
Hardev S. Pall, MD	No disclosure on file
Warren D. Spinner, DO	No disclosure on file
Sokrat Xhaxho, MD	No disclosure on file
Zhixiao Wang, PhD	No disclosure on file
Gerhard Winkler, MD	No disclosure on file
Mwiza Ushe, MD	No disclosure on file
Kameel Karkar, MD	No disclosure on file
Eva Costa Arpin, MD	No disclosure on file
Tammam Dayyoub, MD	No disclosure on file
Eugene Wang, MD	No disclosure on file
Chris Hackett, MA	Mr. Hackett has nothing to disclose.
Ashis H. Tayal, MD	Dr. Tayal has nothing to disclose.
Charles A. Conrad, MD	No disclosure on file
Stefano Messina, MD	No disclosure on file
Mohamed Al-Khaled	No disclosure on file
Yuliya Snyder, MD	Dr. Snyder has nothing to disclose.
Klaus Hansen, MD	No disclosure on file
Adam D. Falchook, MD	No disclosure on file
Ramon L. Rodriguez Cruz, MD, FAAN	The institution of Dr. Rodriguez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie. The institution of Dr. Rodriguez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus . The institution of Dr. Rodriguez has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. The institution of Dr. Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Boston Scientific. The institution of Dr. Rodriguez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbott. The institution of Dr. Rodriguez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. The institution of Dr. Rodriguez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Rodriguez has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Kyoway Kirin. The institution of Dr. Rodriguez has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Rodriguez has received research support from Cerevance. The institution of Dr. Rodriguez has received research support from Neuraly. The institution of Dr. Rodriguez has received research support from Impax. The institution of Dr. Rodriguez has received research support from Teva. The institution of Dr. Rodriguez has received research support from Neurocrine. Dr. Rodriguez has received publishing royalties from a publication relating to health care.
Tzu-Ching Wu, MD	Dr. Wu has nothing to disclose.
Scott E. Cooper, MD, PhD	The institution of Dr. Cooper has received research support from NIH.
Francois Ochsner, MD	No disclosure on file
Ramnath Santosh Ramanathan, MD	No disclosure on file
Andrea Falini	No disclosure on file
Patricia S. Mireles, MD	No disclosure on file
Andrew M. Blumenfeld, MD, FAAN	Dr. Blumenfeld has received personal compensation for serving as an employee of The Los Angeles Headache Center. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctors. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GLG. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Revance. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aeon. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Revance. Dr. Blumenfeld has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Blumenfeld has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Blumenfeld has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Allergan. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Teva. Dr. Blumenfeld has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Lilly. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven. Dr. Blumenfeld has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck.
Gil I. Wolfe, MD, FAAN	Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from ArgenX. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
Francis X. Conidi, DO, MS, FAHS, FAAN	No disclosure on file
Laurie J. Ozelius, PhD	The institution of Dr. Ozelius has received research support from NIH. Dr. Ozelius has received intellectual property interests from a discovery or technology relating to health care.
Francois Viallet, MD	No disclosure on file
Giovanni Antonini	No disclosure on file
Sally Dunaway, DPT	Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Dunaway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cure SMA. The institution of Dr. Dunaway has received research support from Cure SMA. The institution of Dr. Dunaway has received research support from Scholar Rock. The institution of Dr. Dunaway has received research support from Ionis Pharmaceuticals.
Wendy E. Kaye, PhD	Dr. Kaye has received personal compensation for serving as an employee of McKing Consulting Corporation. Dr. Kaye has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Association for the Protection of Human Research Participants.
Stefano Jann, MD	No disclosure on file
Sudhakar Tummala, MD, FAAN	Dr. Tummala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for REVHEALTH LLC.
James Guth, MD	No disclosure on file
Neelum T. Aggarwal, MD	Dr. Aggarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant with AtWHealth . Dr. Aggarwal has received personal compensation in the range of $500-$4,999 for serving as a Speaker with VCU Health.
John M. Olichney, MD	No disclosure on file
Faria S. Amjad, MD	Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Amjad has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. An immediate family member of Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myer Squibb. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Amjad has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Piramal.
Lina Shah, MD	No disclosure on file
Cedric Cunanan, MPH	No disclosure on file
Ahmed Itrat, MD	No disclosure on file
Wei W. Ma, MD	Dr. Ma has nothing to disclose.
Sylvia Klineova, MD	Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Klineova has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Klineova has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Jane Larkindale, PhD	Dr. Larkindale has received personal compensation for serving as an employee of PepGen.
Emmeline Lagrange	No disclosure on file
Dustin A. Heldman, PhD	Dr. Heldman has received personal compensation for serving as an employee of Great Lakes NeuroTechnologies Inc.. Dr. Heldman has stock in Great Lakes NeuroTechnologies. The institution of Dr. Heldman has received research support from NIH.
Andrew D. Barreto, MD	No disclosure on file
Linda Leary, MD	No disclosure on file
Jordan S. Dubow, MD	Dr. Dubow has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avadel Pharmaceuticals.
Nan Jiang, MD	No disclosure on file
Orhan H. Akman, PhD	No disclosure on file
Joseph Giuffrida, PhD	No disclosure on file
Claude Nguyen, MD	Dr. Nguyen has nothing to disclose.
Aiesha Ahmed, MD, MBA, FAAN	Dr. Ahmed has stock in Doximity.
Aradia Fu, MD	No disclosure on file
Brittani L. Conway, MD	No disclosure on file
Naomichi Matsumoto	No disclosure on file
Nicholas Thompson	No disclosure on file
Matthias Meergans	No disclosure on file
Brad C. Klein, MD, MBA, FAAN	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Dr. Klein has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AbbVie. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lundbeck. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Impel. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biodelivery Science. The institution of Dr. Klein has received research support from AbbVie. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Shareholder with AppsbyDocs, LLC. Dr. Klein has a non-compensated relationship as a Chair, Practice Management Committee with American Headache Society that is relevant to AAN interests or activities.
Paul Winner, DO, FAAN	Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Allergan. Dr. Winner has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lundbeck. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Winner has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for lilly. The institution of Dr. Winner has received research support from Amgen. The institution of Dr. Winner has received research support from Allergan. The institution of Dr. Winner has received research support from Lundbeck . The institution of Dr. Winner has received research support from Novartis. The institution of Dr. Winner has received research support from Lilly. The institution of Dr. Winner has received research support from Teva. The institution of Dr. Winner has received research support from Supernus. The institution of Dr. Winner has received research support from Biogen. The institution of Dr. Winner has received research support from Avinar. The institution of Dr. Winner has received research support from SAMUS.
Frederick G. Freitag, DO	No disclosure on file
Kiren Kresa-Reahl, MD	Dr. Kresa-Reahl has received personal compensation for serving as an employee of Atara Biotherapeutics Inc.. Dr. Kresa-Reahl has received stock or an ownership interest from Atara Biotherapeutics Inc.
Charles Maitland	No disclosure on file
Leonard Verhagen Metman, MD, PhD	Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbott. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mitsubishi Tanabe. Dr. Verhagen Metman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerevel. Dr. Verhagen Metman has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers.
Robert S. Chudnow, MD	No disclosure on file
Ashwini K. Rao	No disclosure on file
Sergio Stecchi, MD	No disclosure on file
Sanjeeva R. Onteddu, MD, FAAN	Dr. Onteddu has nothing to disclose.
Cinzia Scandellari	No disclosure on file
Lawrence C. Kenyon, MD, PhD	No disclosure on file
Yossi Gilgun-Sherki, PhD	No disclosure on file
Elisabeth B. Marsh, MD, FAAN	Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Academy of Neurology. Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for American Neurological Association. Dr. Marsh has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ACTN. The institution of Dr. Marsh has received research support from American Heart Association. The institution of Dr. Marsh has received research support from National Institutes of Health. The institution of Dr. Marsh has received research support from National Institutes of Health.
David Andrieu	No disclosure on file
Justin P. Martello, MD, FAAN	Dr. Martello has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. Dr. Martello has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Martello has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Martello has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Supernus.
Adam J. Simon, PhD	No disclosure on file
Rachel J. Saunders-Pullman, MD	The institution of Dr. Saunders-Pullman has received research support from NIH, Bigglesworth Family Foundation, Empire Clinical Research Investigatory Program.
Gregory K. Bergey, MD, FAAN	Dr. Bergey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics.
Grant Liu, MD, FAAN	Dr. Liu has received publishing royalties from a publication relating to health care.
Vivien H. Lee, MD, FAAN	Dr. Lee has nothing to disclose.
Caroline Moreau, MD	No disclosure on file
Zachary Simmons, MD, FAAN	Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cytokinetics. The institution of Dr. Simmons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from MT Pharma. The institution of Dr. Simmons has received research support from University of Kansas. The institution of Dr. Simmons has received research support from ALS Association. The institution of Dr. Simmons has received research support from Clene.
Boris A. Kallmann, MD	No disclosure on file
Ramy El Khoury, MD, FAAN	No disclosure on file
Roberta Fantozzi, MD	No disclosure on file
Monica Sciacco, MD	No disclosure on file
Jack J. Chen, PharmD BCPS CGP	No disclosure on file
Joshua Lovinger, MD	No disclosure on file
Lene Andersen	No disclosure on file
Elaine C. Wirrell, MD, FAAN	Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Encoded. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Wirrell has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine. Dr. Wirrell has received publishing royalties from a publication relating to health care.
Marjo Van Der Knaap, MD, PhD	No disclosure on file
Amiram Katz, MD	No disclosure on file
Andrew P. Duker, MD	No disclosure on file
Joao M. De Moraes, MD, PhD	No disclosure on file
Travis Larsh	No disclosure on file
Vincenzo Silani, MD, FAAN	Dr. Silani has nothing to disclose.
Geraldine Faivre, MD	Dr. Faivre has nothing to disclose.
Colin Wernsdoerfer, MD	No disclosure on file
Antonio M. Omuro, MD, FAAN	Dr. Omuro has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as a Consultant for Kiyatec. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pyramid. Dr. Omuro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Curevac. Dr. Omuro has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Opinion in Neurology. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Agios. The institution of Dr. Omuro has received research support from Arcus Biosciences. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from NIH. The institution of Dr. Omuro has received research support from Denovo Biopharma.
Elizabeth A. Shuster, MD	No disclosure on file
Muna Irfan, MD	Dr. Irfan has nothing to disclose.
Divpreet Kaur, MD	No disclosure on file
Steve Chung, MD, FAAN	The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Sean I. Savitz, MD	Dr. Savitz has nothing to disclose.
Konark Malhotra, MD	Dr. Malhotra has nothing to disclose.
Melvin H. Yee, MD	No disclosure on file
Karna D. Sherwood, MD	No disclosure on file
Mirjam R. Heldner, MD	Dr. Heldner has nothing to disclose.
Cynthia Bonilha Da Silva, MD	No disclosure on file
Vishunmurthy S. Hedna, MD	No disclosure on file
Yadira Velazquez-Rodriguez, MD	No disclosure on file
Melissa M. Cortez, DO	Dr. Cortez has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for PCARES.org. The institution of Dr. Cortez has received research support from NIH NINDS. The institution of Dr. Cortez has received research support from Amgen Independent Investigator Award. Dr. Cortez has received personal compensation in the range of $500-$4,999 for serving as a Content Expert, Reviewer, DSMB with NIH RECOVER project.
Jinny O. Tavee, MD	Dr. Tavee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Tavee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Tavee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Tavee has received research support from Woolsey. The institution of Dr. Tavee has received research support from Milken Foundation. Dr. Tavee has received personal compensation in the range of $0-$499 for serving as a Article author with Medlink.
Lucas D. Branco	No disclosure on file
Michele D. Bronson, PhD	No disclosure on file
Aditi Narechania, MD	Dr. Narechania has nothing to disclose.
Karine Blanc Lasserre	No disclosure on file
Adil Maarouf	Adil Maarouf has nothing to disclose.
Elizabeth Gerard, MD	Dr. Gerard has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Pharmaceuticals. The institution of Dr. Gerard has received research support from NIH/NINDS. The institution of Dr. Gerard has received research support from Xenon Pharmaceuticals. The institution of an immediate family member of Dr. Gerard has received research support from NIH. The institution of an immediate family member of Dr. Gerard has received research support from Novo Nordisk. The institution of Dr. Gerard has received research support from Eisai, Inc. (via Stanford University).
Ricky Lee, MD	No disclosure on file
Regina Krel, MD	No disclosure on file
Amre Nouh, MD, FAAN	Dr. Nouh has stock in Openwater.
Masahiro Sonoo	No disclosure on file
Ganesh Asaithambi, MD, FAAN	Dr. Asaithambi has nothing to disclose.
Squire M. Stead, MD, PhD	No disclosure on file
Nancy T. Kung	No disclosure on file
Adrien Maitrot	No disclosure on file
Ashish Pradhan, MD	Dr. Pradhan has received personal compensation for serving as an employee of Genentech. Dr. Pradhan has received stock or an ownership interest from Genetech.
Cristina Motto, MD	No disclosure on file
Anthony E. Lang, MD, FAAN	Dr. Lang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acorda, AFFiRis, Biogen, Denali, Janssen, Intracellular, Kallyope, Lundbeck, Paladin, Retrophin, Roche, Sun Pharma, Theravance, and Corticobasal Degeneration Solutions, Sun Pharma, Medichem, Medtronic, AbbVie and Sunovion. The institution of Dr. Lang has received research support from AbbVie. Dr. Lang has received publishing royalties from a publication relating to health care.
Richard J. Barohn, MD, FAAN	Dr. Barohn has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for NuFactor. The institution of Dr. Barohn has received research support from FDA OPD R01. Dr. Barohn has received intellectual property interests from a discovery or technology relating to health care.
Charles H. Adler, MD, PhD, FAAN	Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Keith R. Edwards, MD, FAAN	No disclosure on file
Eduardo Nobile-Orazio, MD, PhD, FAAN	Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX, Belgium. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for LFB, France. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche, Switzerland. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. Dr. Nobile-Orazio has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen, USA. The institution of Dr. Nobile-Orazio has received research support from Takeda/Shire.
Erin E. Manning, MD	No disclosure on file
Charles Wira	No disclosure on file
Ettore Beghi, MD, FAAN	No disclosure on file
Virginia A. Pujol Lereis, MD	Dr. Pujol Lereis has nothing to disclose.
Andrew A. Wolff, MD	No disclosure on file
Sarah I. Sheikh, BM Bch, MSc, MRCP	No disclosure on file
Mauricio F. Farez, MD	Dr. Farez has nothing to disclose.
Sylvain Chouinard, MD	No disclosure on file
Deborah Raymond	The institution of Ms. Raymond has received research support from NIH.
Luigi M. Barbato, MD	Dr. Barbato has nothing to disclose.
Moshe A. Mizrahi, MD, FAAN	Dr. Mizrahi has nothing to disclose.
Serefnur Ozturk, MD	No disclosure on file
John H. Kanter	No disclosure on file
Ahn Hee Seung	No disclosure on file
Mazen M. Dimachkie, MD, FAAN	Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EcoR1 Capital, LLC. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cello Health BioConsulting, previously Defined Health. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Octapharma. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RAF-5. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Houston NeuroCare. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shire. Dr. Dimachkie has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for RaPharma/UCB. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ArgenX. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. An immediate family member of Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kezar. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Catalyst. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SCHOLAR Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jenssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amazentis / Vandria. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SANEM. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medlink. Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Rock. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme . Dr. Dimachkie has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roivant . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TACT / Treat NMD. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clinical Neurological Society of America, Inc . Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ig Society, Inc. Dr. Dimachkie has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abcuro. Dr. Dimachkie has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Covance / Labcorp. The institution of Dr. Dimachkie has received research support from CSL Behring. The institution of Dr. Dimachkie has received research support from Orphazyme. The institution of Dr. Dimachkie has received research support from FDA-OOPD. The institution of Dr. Dimachkie has received research support from NIH. Dr. Dimachkie has received intellectual property interests from a discovery or technology relating to health care. Dr. Dimachkie has received publishing royalties from a publication relating to health care.
Melissa Armstrong, MD, MSc, FAAN	The institution of Dr. Armstrong has received research support from National Institute of Aging. The institution of Dr. Armstrong has received research support from Florida Department of Health. The institution of Dr. Armstrong has received research support from Lewy Body Dementia Association. Dr. Armstrong has received research support from Parkinson Foundation. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Clinical Trials Consortium. Dr. Armstrong has received personal compensation in the range of $5,000-$9,999 for serving as a DSMB member with Alzheimer's Disease Cooperative Study. Dr. Armstrong has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to AAN interests or activities.
Susan B. Bressman, MD, FAAN	The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Gonzalo Revuelta, DO	The institution of Dr. Revuelta has received research support from NIH.
Lissa Brod, MD	No disclosure on file
Shifang Liu	No disclosure on file
Brian Grosberg, MD	Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Linpharma pharmaceuticals. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Theranica . Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven. Dr. Grosberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Grosberg has stock in Theranica. The institution of Dr. Grosberg has received research support from Theranica. The institution of Dr. Grosberg has received research support from Amgen. The institution of Dr. Grosberg has received research support from Abbvie. The institution of Dr. Grosberg has received research support from Eli Lilly. The institution of Dr. Grosberg has received research support from Teva. The institution of Dr. Grosberg has received research support from Neurolief. Dr. Grosberg has received publishing royalties from a publication relating to health care.
Anne Josiah, MD	Dr. Josiah has nothing to disclose.
Robert Avery, DO, MSCE	Dr. Avery has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ovid. Dr. Avery has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. The institution of Dr. Avery has received research support from NIH. Dr. Avery has received intellectual property interests from a discovery or technology relating to health care.
David R. Benavides, MD, PhD, FAAN	The institution of Dr. Benavides has received research support from NIH/NINDS. The institution of Dr. Benavides has received research support from F. Hoffman La Roche Ltd.
Leslie J. Vaughan, RPh	No disclosure on file
Joseph Schindler, MD	Dr. Schindler has received personal compensation for serving as an employee of Aeromics. Dr. Schindler has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Aeromics. Dr. Schindler has received stock or an ownership interest from Aeromics. Dr. Schindler has received publishing royalties from a publication relating to health care.
Yu-Qiong Niu, PhD	No disclosure on file
Julieta E. Arena, MD	Dr. Arena has nothing to disclose.
Carlo S. Tornatore, MD	Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Serono. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Tornatore has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Jared Cook	No disclosure on file
Iftekhar Ahmed, MD, PC, FAAN	Dr. Ahmed has nothing to disclose.
Daniel Vela-Duarte, MD	Dr. Vela-Duarte has nothing to disclose.
Jackson A. Narrett, MD	Mr. Narrett has nothing to disclose.
Eugen J. Boltshauser, MD, FAAN	No disclosure on file
Jora Xhaxho	No disclosure on file
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. The institution of Dr. Greer has received research support from Becton, Dickinson and Company. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care.
Friedemann Paul	The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe PC (MTPC). The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aarhus University. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Paul has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CELGENE. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ACRELION. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Viela Bio. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pfizter. Dr. Paul has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck Serono. The institution of Dr. Paul has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer.
Edward Fox, MD, PhD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Ada Francia, MD	No disclosure on file
Matthew S. Robbins, MD, FAAN	Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. Dr. Robbins has received publishing royalties from a publication relating to health care. Dr. Robbins has a non-compensated relationship as a Board of Directors member, Education Program speaker with American Headache Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Board of Directors member, Education Program speaker with New York State Neurological Society that is relevant to AAN interests or activities. Dr. Robbins has a non-compensated relationship as a Editorial Board Member with Continuum, American Academy of Neurology that is relevant to AAN interests or activities.
Harry T. Whelan, MD	No disclosure on file
Matthew B. Maas, MD, FAAN	The institution of Dr. Maas has received research support from National Institutes of Health.
Tamela Stuchiner	Ms. Stuchiner has nothing to disclose.
Anthony V. Caparso	No disclosure on file
Sheryl Martin-Schild, MD, PhD, FAAN	No disclosure on file
Stanley L. Cohan, MD, PhD, FAAN	Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb (Celgene). Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Icometrix. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for sanofi genzyme. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novartis. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche Genentech. Dr. Cohan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Cohan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Cohan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Icometrix.
Judy Jia, MD	No disclosure on file
Amy Chan, MD	Dr. Chan has nothing to disclose.
Michael Glantz, MD, FAAN	No disclosure on file
David Devos	The institution of Mr. Devos has received research support from Alterity.
Emmanuel Roze, MD, PhD	Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for merz. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving as a Consultant for orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Orkyn. Dr. Roze has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for elivie. Dr. Roze has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aguettant. The institution of Dr. Roze has received research support from merz. The institution of Dr. Roze has received research support from Orkyn. Dr. Roze has received research support from elivie. The institution of Dr. Roze has received research support from allergan. The institution of Dr. Roze has received research support from fondation desmarest. The institution of Dr. Roze has received research support from everpharma. Dr. Roze has received research support from AMADYS. The institution of Dr. Roze has received research support from ADCY5.org. The institution of Dr. Roze has received research support from agence nationale de la recherche. The institution of Dr. Roze has received research support from société française de médecine esthétique. The institution of Dr. Roze has received research support from dystonia medical research foundation.
Milena Stosic, MD	No disclosure on file
Hayrettin Tumani, MD	Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Tumani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Miguel J. Lainez, MD, PhD, FAAN	No disclosure on file
Harini Sarva, MD, FAAN	Dr. Sarva has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novo Nordisk. Dr. Sarva has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novo Nordisk. The institution of Dr. Sarva has received research support from Insightec. The institution of Dr. Sarva has received research support from NeuroNext. The institution of Dr. Sarva has received research support from Neuroderm. The institution of Dr. Sarva has received research support from Covance. The institution of Dr. Sarva has received research support from Prevail. The institution of Dr. Sarva has received research support from Bluerock Therapeutics. The institution of Dr. Sarva has received research support from Biogen. The institution of Dr. Sarva has received research support from Roche. The institution of Dr. Sarva has received research support from National Institute of Aging. The institution of Dr. Sarva has received research support from Michael J Fox Foundation. The institution of Dr. Sarva has received research support from Novo Nordisk. The institution of Dr. Sarva has received research support from Bukwang. The institution of Dr. Sarva has received research support from Bial. The institution of Dr. Sarva has received research support from Cerevance. The institution of Dr. Sarva has received research support from UCB.
James Conners, MD	The institution of Dr. Conners has received research support from nih.
Martin Marziniak, PhD	No disclosure on file
Sophie Drapier, MD	No disclosure on file
Richard Salazar, MD, FAAN	No disclosure on file
Nadia Tenenbaum, MD	Dr. Tenenbaum has received personal compensation for serving as an employee of EMS Serono. Dr. Tenenbaum has stock in EMS Serono.
Amrit Misra, MD, PhD	No disclosure on file
Maximiliano A. Hawkes, MD	Dr. Hawkes has nothing to disclose.
Van S. Miller, MD, PhD	No disclosure on file
Anthony S. Kim, MD	No disclosure on file
Gerald So, MD	No disclosure on file
Amy T. Waldman, MD	Dr. Waldman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SwanBio. An immediate family member of Dr. Waldman has stock in Pfizer. The institution of Dr. Waldman has received research support from Ionis Pharmaceuticals. Dr. Waldman has received publishing royalties from a publication relating to health care.
Laurie Wagner	Laurie Wagner has nothing to disclose.
Shashidhar Kori, MD	Dr. Kori has received personal compensation for serving as an employee of Novilla Pharma. Dr. Kori has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Satsuma Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Tonix Pharma. Dr. Kori has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Exalys Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for NewBio Pharma. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Consultant for Afsci Pharma. Dr. Kori has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Trigemina Inc. Dr. Kori has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Novilla Pharma. Dr. Kori has received stock or an ownership interest from Novilla Pharma. Dr. Kori has received stock or an ownership interest from NewBio Pharma. Dr. Kori has received stock or an ownership interest from Tonix Pharma. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received intellectual property interests from a discovery or technology relating to health care. Dr. Kori has received personal compensation in the range of $0-$499 for serving as a Reviewer of grant applications with Department of Defense.
Rajeev Garg, MD, FAAN	No disclosure on file
Joseph R. Berger, MD, FAAN	Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb/Celgene. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono/Merck. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen/J&J. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Morphic. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuVIR. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seagen. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cellevolve. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MAPI. Dr. Berger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ExcisionBio. Dr. Berger has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for WebMD. The institution of Dr. Berger has received research support from Biogen. The institution of Dr. Berger has received research support from Genentech/Roche.
Venu Parachuri, MD	No disclosure on file
Lisa M. Shulman, MD, FAAN	The institution of Dr. Shulman has received research support from NIH. Dr. Shulman has received publishing royalties from a publication relating to health care. Dr. Shulman has received publishing royalties from a publication relating to health care.
Leah Gaedeke, MSN, FNP-BC	No disclosure on file
Sara El Alaoui	No disclosure on file
Maromi Nei, MD	No disclosure on file
Nolan Williams, MD	No disclosure on file
Anthony R. Riela, MD, FAAN	No disclosure on file
Ethan M. Goldberg, MD, PhD	Dr. Goldberg has nothing to disclose.
Angela Wabulya, MB ChB	Dr. Wabulya has nothing to disclose.
Artin Minaeian, MD	No disclosure on file
Michelle Greer	No disclosure on file
John G. Burch, MD, FAAN	No disclosure on file
Jina M. Youn, MD, MS	Dr. Youn has nothing to disclose.
Varoon R. Thavapalan, MD	No disclosure on file
Heeral Mehta, MD	No disclosure on file
Jacquelyn Laplant	No disclosure on file
John Probasco, MD, FAAN	Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch Neurology. The institution of Dr. Probasco has received research support from Roche/Genentech.
Guido Cavaletti	No disclosure on file
Jean M. Schoenen, MD, PhD	No disclosure on file
Heather Jordan, MPH, CPH, MCHES	No disclosure on file
Keiran Tuck, MD	No disclosure on file
Charles R. Guttmann	Charles R.G. Guttmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica SA. Charles R.G. Guttmann has received stock or an ownership interest from Alnylam. Charles R.G. Guttmann has received stock or an ownership interest from Roche. Charles R.G. Guttmann has received stock or an ownership interest from Novartis. Charles R.G. Guttmann has received stock or an ownership interest from Arrowhead Pharmaceuticals. Charles R.G. Guttmann has received stock or an ownership interest from Protalix. Charles R.G. Guttmann has received stock or an ownership interest from Promethee. Charles R.G. Guttmann has received stock or an ownership interest from GSK. Charles R.G. Guttmann has received stock or an ownership interest from Sangamo. Charles R.G. Guttmann has received stock or an ownership interest from Alcon. Charles R.G. Guttmann has received stock or an ownership interest from Cocrystal Pharma. The institution of Charles R.G. Guttmann has received research support from NIH. The institution of Charles R.G. Guttmann has received research support from McGill University. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from BrightFocus Foundation. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from University of Connecticut Health Center. The institution of Charles R.G. Guttmann has received research support from U.S. Office of Naval Research.
Elissa A. Ritt	No disclosure on file
Hector R. Martinez, MD	No disclosure on file
Maria Goicochea	No disclosure on file
Antonios Bayas	No disclosure on file
Joachim M. Baehring, MD, FAAN	No disclosure on file
Haluk Gumus	No disclosure on file
Licia Grazzi, MD	Dr. Grazzi has received personal compensation in the range of $0-$499 for serving as a Consultant for EliLilly. Dr. Grazzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for allergan-abbvie.
Fabio Nascimento, MD	Dr. Nascimento has received publishing royalties from a publication relating to health care. Dr. Nascimento has a non-compensated relationship as a Editorial Team Member with Neurology RFS that is relevant to AAN interests or activities. Dr. Nascimento has a non-compensated relationship as a Production Team with Neurology Podcast that is relevant to AAN interests or activities.
Jeremy M. Jones, DO	No disclosure on file
Jinsan Lee	No disclosure on file
Karen Feins	No disclosure on file
Kyle Smoot, MD, FAAN	No disclosure on file
Antonino Uncini, MD	No disclosure on file
Sarah E. Vollbracht, MD	Dr. Vollbracht has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Vollbracht has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Allergan.
Chiayi Chen, PhD, RN	Dr. Chen has nothing to disclose.
Catherine Tegeler	Ms. Tegeler has nothing to disclose.
Sung Lee	No disclosure on file
Mark S. George, MD	No disclosure on file
Adel Alhazzani, MD, FRCPC, FAAN	Dr. Alhazzani has nothing to disclose.
Ahmet Hakan Ekmekci, PhD	No disclosure on file
Ulrich Fulda, MD	No disclosure on file
Ismael Calandri, MD	Dr. Calandri has nothing to disclose.
Daniel Friedman, MD	The institution of Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Study Consortium (non-profit). Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Meili Technology. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Friedman has stock in Neuroview Technology. The institution of Dr. Friedman has received research support from NIH. The institution of Dr. Friedman has received research support from CDC. The institution of Dr. Friedman has received research support from Epitel. The institution of Dr. Friedman has received research support from Neuropace. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received publishing royalties from a publication relating to health care. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with SK Life Sciences. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with AAN. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Travel Reimbursement with Epilepsy Foundation of America.
Akshat Katyayan, MD	No disclosure on file
Raymond Hupperts	No disclosure on file
Bhuvin Buddhdev	No disclosure on file
Susan Huyck	No disclosure on file
Oscar Soto, MD, PhD	Dr. Soto has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. The institution of Dr. Soto has received research support from CTSI.
Anne-Gaelle Benoit	No disclosure on file
Carrie K. Grouse, MD, FAAN	The institution of Dr. Grouse has received research support from Siemens.
Maria Pia Sormani	Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Geneuro. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Maria Pia Sormani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Maria Pia Sormani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Kay Cheong Teo, MD	No disclosure on file
Lauren Wood	No disclosure on file
Lucio Santoro	No disclosure on file
Marc Verin	Mr. Verin has nothing to disclose.
Christoph Heesen	No disclosure on file
Andrew Ji	No disclosure on file
Nazanin K. Majd, MD	No disclosure on file
Scott R. Jordan	No disclosure on file
Charles H. Tegeler, MD	Dr. Tegeler has nothing to disclose.
Paul S. Fishman, MD, PhD	No disclosure on file
Elizabeth A. Baraban, PhD, MPH	The institution of Dr. Baraban has received research support from Boehringer Ingelheim.
Kerry L. Knievel, DO	Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for amgen . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven . An immediate family member of Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Pfizer. Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sanders and Parks. The institution of Dr. Knievel has received research support from Abbvie . The institution of Dr. Knievel has received research support from Alder.
Dominique Monlezun, Jr	No disclosure on file
Maria Malentacchi	No disclosure on file
Ben Lenail	No disclosure on file
Eithan Kotkowski, MD, PhD	Dr. Kotkowski has nothing to disclose.
Gorana Capkun	No disclosure on file
Winona Tse, MD	Dr. Tse has nothing to disclose.
Joshua Bonkowsky, MD, PhD	Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Passage Bio. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Autobahn. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bonkowsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bonkowsky has stock in Orchard. The institution of Dr. Bonkowsky has received research support from NIH. The institution of Dr. Bonkowsky has received research support from ELA. An immediate family member of Dr. Bonkowsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care. Dr. Bonkowsky has received publishing royalties from a publication relating to health care.
Donna George, MD	No disclosure on file
Emilee C. Connors	No disclosure on file
Shira McMahan, DO	No disclosure on file
Michael Hutchinson, MD	Dr. Hutchinson has nothing to disclose.
Alexandre Eusebio, MD	No disclosure on file
Laetitia Mauger	No disclosure on file
Swati Karmarkar, MD	No disclosure on file
Adel Eladl	No disclosure on file
Eric Liotta, MD	Dr. Liotta has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Penumbra. The institution of Dr. Liotta has received research support from NIH-NINDS.
Laurie A. Schluter, RN, MSN, FNP	No disclosure on file
Felix M. Veloso, MD, FAAN	No disclosure on file
Peter T. Fox, MD	No disclosure on file
Wes Cetnarowski	No disclosure on file
Fatmah Al Zahmi, MBBS	No disclosure on file
Grace M. McMacken, MD	No disclosure on file
Michael Sweeney, MD	No disclosure on file
Lisa Meng	No disclosure on file
Bahman Jabbari, MD, FAAN	No disclosure on file
Teena Shetty, MD, FAAN	Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from GE-NFL.
Alexander George	No disclosure on file
Sebastian F. Ameriso, MD	Dr. Ameriso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PHRI. Dr. Ameriso has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bayer, Boehringer, Abbott, AstraZeneca.
Jinchen Yang, PhD	No disclosure on file
Anca S. Popescu, MD, FAAN	No disclosure on file
Asim Mahmood	No disclosure on file
Amado San Luis, MD	No disclosure on file
Marc W. Haut, PhD	No disclosure on file
Neeta S. Duggal, MD	No disclosure on file
Andrew G. Inocelda, PA	No disclosure on file
Elizabeth T. Kinter, PhD	No disclosure on file
Wi-Sun Ryu	No disclosure on file
Heather Beckstrom	No disclosure on file
Lindsay Rechtman	The institution of Lindsay Rechtman has received research support from ATSDR.
Marwa Elamin, MD	Dr. Elamin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche .
David K. Li, MD	Dr. Li has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Academy of Health Care Learning. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme. Dr. Li has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Consortium of MS Centers.
Derrece K. Reid, MD	No disclosure on file
Leslie A. Meltzer, PhD	No disclosure on file
Pavis Laengvejkal, MD	No disclosure on file
Isabella L. Simone	No disclosure on file
Mark Guttman, MD	No disclosure on file
Tissa Wijeratne, OAM MD PhD, FAAN	Dr. Wijeratne has nothing to disclose.
Rocio C. Garcia Santibanez, MD, FAAN	Dr. Garcia Santibanez has nothing to disclose.
Anna Roy	No disclosure on file
Elizabeth Nowak	No disclosure on file
Nirosen Vijiaratnam, MD	No disclosure on file
Wataru Hagiwara	No disclosure on file
Laura De Giglio	No disclosure on file
Naotoshi Yamamura	No disclosure on file
Krai Chatamra, PhD	No disclosure on file
Christopher Clough, FRCP	No disclosure on file
Giovanna Vaula, MD	No disclosure on file
Roger Tam, PhD	The institution of Dr. Tam has received research support from Natural Sciences and Engineering Research Council. The institution of Dr. Tam has received research support from Praxis Spinal Cord Institute.
George E. Koch	No disclosure on file
Victoria Barghout, PhD	No disclosure on file
Nicholas Milano, MD	Dr. Milano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Jackson kelly.
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Genzyme.
Bhooma R. Aravamuthan, MD, PhD	Dr. Aravamuthan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine Biosciences. An immediate family member of Dr. Aravamuthan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SK Life Science, Inc.. Dr. Aravamuthan has received research support from National Institute of Neurological Disorders and Stroke. Dr. Aravamuthan has received publishing royalties from a publication relating to health care.
Wolfgang Walter Feneberg, MD	No disclosure on file
Sebastian F. Von Rosenstiel, MD, PhD	No disclosure on file
Ankit Pahwa	Ankit Pahwa has nothing to disclose.
Shingo Konno, MD	Dr. Konno has nothing to disclose.
Ron Hashmonay, MD	No disclosure on file
Kaustubh S. Limaye, MD	Dr. Limaye has nothing to disclose.
Andrea Boan, PhD, MSCR	No disclosure on file
Hans Tu, MBBS, FRACP	No disclosure on file
Sergio Slawka	No disclosure on file
Frederic Blanc	No disclosure on file
Maura Pugliatti, MD	No disclosure on file
Alexandra Sibley	No disclosure on file
Michael Epstein	No disclosure on file
Robert R. Bulger, MD	No disclosure on file
Pietro Iaffaldano	No disclosure on file
Katherine Grosset	No disclosure on file
Davide Pareyson, MD	No disclosure on file
Martin E. Sanders, MD	No disclosure on file
Sandro Iannaccone	No disclosure on file
Gerard Besson	No disclosure on file
Rebecca L. Sugg, MD, FAAN	Dr. Sugg has nothing to disclose.
Peter T. Schmidt, PhD	No disclosure on file
Gulshan S. Oberoi, MD	No disclosure on file
Daveena Meeks	No disclosure on file
Joseph Posner	No disclosure on file
Jessica Mandrioli	No disclosure on file
Subhashie Wijemanne, MD	No disclosure on file
Asif A. Khan, MD	No disclosure on file
Wendy Chao, DO	No disclosure on file
Yogesh Moradiya, MD	No disclosure on file
Timothy Spelman	No disclosure on file
Weizhen Wang, MD	No disclosure on file
Deepa Dash, MD, DM	Dr. Dash has nothing to disclose.
Daniel T. Lackland, PhD	An immediate family member of Prof. Lackland has received personal compensation for serving as an employee of Sound Pharmacetical. Prof. Lackland has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley Publishing. Prof. Lackland has received publishing royalties from a publication relating to health care.
Donna Tippett	No disclosure on file
Pirouz Piran, MD	No disclosure on file
Laura R. Gwyn	Mrs. Gwyn has nothing to disclose.
Charles Makin	No disclosure on file
Juanzhi Fang	No disclosure on file
Stephen Carcieri	No disclosure on file
Ceyla Irkec, MD	No disclosure on file
Vijay Sharma	No disclosure on file
Massimo Corbo	No disclosure on file
Muhib Khan, MD, FAAN	The institution of Dr. Khan has received research support from NINDS. The institution of Dr. Khan has received research support from Genentech. The institution of Dr. Khan has received research support from Spectrum Health-MSU alliance. Dr. Khan has received research support from NIH.
Oliver Grauer	No disclosure on file
Valeria T. Barletta, MD, PhD	Dr. Barletta has nothing to disclose.
Paola De Martino, MD, PhD	No disclosure on file
Gencer Genc, MD	No disclosure on file
Rigmor Jensen, MD	No disclosure on file
Elizabeth Keiner	No disclosure on file
Leslaw Zub	No disclosure on file
Stephanie Holmes	No disclosure on file
Stefano Tamburin	No disclosure on file
Jean-Yves Delattre, MD	No disclosure on file
Konstantin E. Balashov, MD, PhD, FAAN	Dr. Balashov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Alyana Samai	No disclosure on file
Takamichi Kanbayashi	No disclosure on file
Xiaoping Li	No disclosure on file
Shigeo Murayama, MD, PhD	No disclosure on file
Cesar Escamilla Ocanas	No disclosure on file
Cuiping Chen	No disclosure on file
Lauren Dowell	No disclosure on file
David T. Asuzu	No disclosure on file
Dillon Y. Chen, MD, PhD	No disclosure on file
Colleen Hanlon	No disclosure on file
Kiyonori Kai	No disclosure on file
Stephanie Nguyen	No disclosure on file
Jeremy M. Shefner, MD, PhD, FAAN	Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Uniqure. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Clene. Dr. Shefner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cytokinetics. Dr. Shefner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for annexon. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SwanBio. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurosense. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for swanbio. Dr. Shefner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vertex. Dr. Shefner has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Shefner has received research support from NIH. The institution of Dr. Shefner has received research support from Mitsubishi Tanabe Pharma America. The institution of Dr. Shefner has received research support from ALS Association. The institution of Dr. Shefner has received research support from Amylyx. The institution of Dr. Shefner has received research support from BIogen. The institution of Dr. Shefner has received research support from Cytokinetics. The institution of Dr. Shefner has received research support from IONIS. The institution of Dr. Shefner has received research support from Healey Center for ALS.
Dushyant R. Damania, MBBS	No disclosure on file
Erin Bange	No disclosure on file
Matteo Caporro, MD, PhD	No disclosure on file
TK Banerjee	No disclosure on file
Adam S. Sprouse-Blum, MD	Dr. Sprouse-Blum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Neuropharma. Dr. Sprouse-Blum has received personal compensation in the range of $5,000-$9,999 for serving as a CME presenter with American Headache Society.
Nicole Wolf	No disclosure on file
Pinelopi Tsouni	No disclosure on file
Annu Aggarwal, MD	No disclosure on file
Fadi H. Delly, MD	Dr. Delly has nothing to disclose.
Jorge Zamudio, MD, MBA	Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received personal compensation for serving as an employee of Abbvie. Dr. Zamudio has received stock or an ownership interest from Abbvie .
Abuhuzeifa Abubakr, MB, FRCP, FRCPI, FAAN	No disclosure on file
Zelko Matkovic, MD	No disclosure on file
Mohsin Maqbool, MD	No disclosure on file
Amitha Ananth, MD	Dr. Ananth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Reata Therapeutics. The institution of Dr. Ananth has received research support from Acadia Pharmaceuticals.
Philip Van Damme	The institution of Dr. Van Damme has received research support from CSL Behring.
Zabeen K. Mahuwala, MD, FAAN	Dr. Mahuwala has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for alexion. The institution of Dr. Mahuwala has received research support from UCB, . The institution of Dr. Mahuwala has received research support from Alexion . The institution of Dr. Mahuwala has received research support from argenx . The institution of Dr. Mahuwala has received research support from immunovant.
Erin C. Golden, MD	No disclosure on file
David Aharonoff, MD	No disclosure on file
Giancarlo Logroscino, MD, PhD, FAAN	Dr. Logroscino has nothing to disclose.
Vishal Jani, MD	Dr. Jani has nothing to disclose.
John Moossy, MD	No disclosure on file
Walter Poellmann, MD	No disclosure on file
Eric Mittelmann, MD	No disclosure on file
Marta Campagnolo	No disclosure on file
Michael Barbe	No disclosure on file
Victor Fung, MD, MBBS, PhD	Dr. Fung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Fung has received publishing royalties from a publication relating to health care.
Chiara Dalla Torre	No disclosure on file
Tomas Kalincik	Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Health and Medical Research Council. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MS Research Australia. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for WebMD Global. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi Genzyme. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Teva. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for BioCSL. Tomas Kalincik has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck. Tomas Kalincik has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tomas Kalincik has received research support from Biogen. The institution of Tomas Kalincik has received research support from Novartis. The institution of Tomas Kalincik has received research support from Genzyme. The institution of Tomas Kalincik has received research support from Roche. The institution of Tomas Kalincik has received research support from Celgene. The institution of Tomas Kalincik has received research support from Merck. The institution of Tomas Kalincik has received research support from MSBase Foundation. The institution of Tomas Kalincik has received research support from ARSEP and EDMUS Foundations. The institution of Tomas Kalincik has received research support from MS Research Australia. The institution of Tomas Kalincik has received research support from National Health and Medical Research Council. The institution of Tomas Kalincik has received research support from Australian Research Council. The institution of Tomas Kalincik has received research support from MS Society. The institution of Tomas Kalincik has received research support from Trish Foundation. Tomas Kalincik has a non-compensated relationship as a scientific leadership group vice-chair with MSBase Foundation that is relevant to AAN interests or activities.
Claes Martin, PhD	No disclosure on file
Simrat Randhawa, MD	No disclosure on file
Christopher Lines	No disclosure on file
Ajay Kumar, MBBS	No disclosure on file
Angelo Schenone	No disclosure on file
Robert L. Knobler, MD, PhD	No disclosure on file
Gregorio Petrirena	No disclosure on file
James E. Kim, MD	No disclosure on file
Robert Terziev	No disclosure on file
Biao Lu	No disclosure on file
Elias Johansson	No disclosure on file
Trenton M. Myers, MD	No disclosure on file
Luc Defebvre	No disclosure on file
Kurt Marhardt	No disclosure on file
Damoun Safarpour, MD, PhD	No disclosure on file
Tomihisa Yokoyama	No disclosure on file
Arnaud Lacour	No disclosure on file
Claudio Gobbi, MD	The institution of Dr. Gobbi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Almirall, Biogen Idec, Celgene, Sanofi, Merck, Novartis, Teva Pharma, Roche.. Dr. Gobbi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Almirall, Biogen Idec, Celgene, Sanofi, Merck, Novartis, Teva Pharma, Roche..
Ayman P. Tourbah	No disclosure on file
Leo Wolansky, MD	The institution of Dr. Wolansky has received research support from Guerbet.
Patrick Vermersch	Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Prashanth Krishnamohan, MD	Dr. Krishnamohan has nothing to disclose.
Sandra Jimenez, MD	Dr. Jimenez has nothing to disclose.
Christian Cornelissen	No disclosure on file
Guojun Bu	No disclosure on file
Pawel Tacik, MD	No disclosure on file
Antonio Carolei, MD	No disclosure on file
Akio Ikeda, MD	No disclosure on file
Elfadil M. Hassan, MBBS, FRCP	No disclosure on file
Chang Shek Kwan, MD	Dr. Kwan has nothing to disclose.
Domenico Merante	No disclosure on file
Macaulay Okwuokenye	No disclosure on file
Stefano Ruggieri	No disclosure on file
Samuel Komoly	No disclosure on file
Vikas Kotagal, MD, FAAN	Dr. Kotagal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Society. The institution of Dr. Kotagal has received research support from NIH. The institution of Dr. Kotagal has received research support from VA Healthcare System.
Angelo Ghezzi, MD	No disclosure on file
Sandrine Jeangette	No disclosure on file
Ailsa Fulton, MD	No disclosure on file
Robyn Schecter	No disclosure on file
Csilla Rozsa, MD	No disclosure on file
Monica Mann, PhD	No disclosure on file
Magdolna Simo, MD	No disclosure on file
Paola Cavalla	No disclosure on file
Gigliola Fagiolari	No disclosure on file
Richard A. Macdonell, MD, FAAN	Dr. Macdonell has nothing to disclose.
John Vissing, MD	Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amicus therapeutics. Prof. Vissing has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sarepta. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharma AG. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genethon. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Biopharma. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lupin. Prof. Vissing has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Edgewise Therapeutics. The institution of Prof. Vissing has received research support from Rigshospitalet. The institution of Prof. Vissing has received research support from UCB Pharma. The institution of Prof. Vissing has received research support from Sanofi. The institution of Prof. Vissing has received research support from NOVO Foundation. Prof. Vissing has received research support from Reneo Pharma. Prof. Vissing has received research support from Janssen Pharmaceuticals.
Michelle L. Mellion, MD	Dr. Mellion has received personal compensation for serving as an employee of PepGen. Dr. Mellion has stock in PepGen.
Harald Murck	No disclosure on file
Xiaoyang Lan, PhD	No disclosure on file
Donna L. Masterman, MD	No disclosure on file
Walter Royal III, MD	No disclosure on file
Cinzia Cordioli, MD	Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Almirall. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Cordioli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Maurice M. Ohayon, MD, PhD, DSc	The institution of Dr. Ohayon has received research support from Jazz pharmaceuticals. The institution of Dr. Ohayon has received research support from Takeda Pharmaceuticals.
Carlo Colosimo, MD	No disclosure on file
Eric T. Wong, MD, FAAN	Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cancer Commons. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Eric J. Pappert, MD	No disclosure on file
James Sheridan, PhD	No disclosure on file
Amanda P. Jones	No disclosure on file
Kathryn A. Giles, MD	No disclosure on file
Suresh Kumar, MD	Dr. Kumar has nothing to disclose.
Richard M. Ransohoff, MD	Dr. Ransohoff has received personal compensation for serving as an employee of Third Rock Ventures. Dr. Ransohoff has stock in Biogen. Dr. Ransohoff has received intellectual property interests from a discovery or technology relating to health care.
Josep Gamez, MD, PhD	The institution of Dr. Gamez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring. The institution of Dr. Gamez has received research support from Government of Spain (FIS FEDER).
Henry J. Kaminski, MD, FAAN	The institution of Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Kaminski has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cabaletta Bio. Dr. Kaminski has stock in ARC Biotechnology. The institution of Dr. Kaminski has received research support from National Institutes of Health. Dr. Kaminski has received publishing royalties from a publication relating to health care.
Harold Koendgen, MD	Dr. Koendgen has received personal compensation for serving as an employee of F. Hoffmann-La Roche Ltd. Dr. Koendgen has received stock or an ownership interest from F. Hoffmann-La Roche Ltd .
Pietro Osvaldo Luigi Annovazzi	No disclosure on file
Joerg Windsheimer, MD	No disclosure on file
Timothy Cunniff, PharmD	Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
Sanjay Gandhi, MD	Dr. Gandhi has received personal compensation for serving as an employee of Teva Pharmaceuticals.
Hideki Garren, MD, PhD	No disclosure on file
Wai-Kuen Leong, MD	Dr. Leong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen Australia.
Carmen Castrillo-Viguera	Dr. Castrillo-Viguera has received personal compensation for serving as an employee of Biogen. Dr. Castrillo-Viguera has received stock or an ownership interest from Biogen.
Roshan L. Koul, MD, DM, FRCPCH	No disclosure on file
Guido Sabatella	Guido Sabatella has received personal compensation for serving as an employee of Alexion.
Lawrence Hewitt, PhD	No disclosure on file
Annie Zhang	No disclosure on file
Peter McCroskery	No disclosure on file
Peter Aupperle	No disclosure on file
James Potts	No disclosure on file
Kevin O'Connor, FRACP, MB, BCh, BAO	No disclosure on file
Lecio Figueira Pinto, MD	No disclosure on file
Paulo P. Fontoura, MD, PhD, FAAN	Dr. Fontoura has received personal compensation for serving as an employee of F. Hoffmann La Roche. Dr. Fontoura has stock in Roche Pharmaceuticals.
Marilyn R. Semenchuk, PharmD, MSc	No disclosure on file
Julia Tsai	No disclosure on file
Annette Sauter, PhD	Dr. Sauter has received personal compensation for serving as an employee of F.Hoffmann-La Roche .
Andreas Lysandropoulos	Andreas Lysandropoulos has nothing to disclose.
Michael R. Edwards, PhD	No disclosure on file
Randall Owen	No disclosure on file
Jimmy Schiemann	No disclosure on file
Teesta B. Soman, MD, MBBS	No disclosure on file
Rozalina Dimitrova, MD, MPH	No disclosure on file
Anna Forsythe	No disclosure on file
Claudia Prada	No disclosure on file
Kavita Sail, PhD	No disclosure on file
Michael A. Vogelbaum, MD, PhD, FACS	No disclosure on file
Dorota Koziarska	No disclosure on file
Clement Francois	No disclosure on file
Devangi S. Mehta, PhD	No disclosure on file
Amy Guo	No disclosure on file
James M. Meyer, PharmD	No disclosure on file
Andrew Lee	No disclosure on file
Augusto Grinspan, MD	No disclosure on file
Radhika Patel, MD	No disclosure on file
Sami Fam	Sami Fam has received personal compensation for serving as an employee of Alexion Pharmaceuticals. Sami Fam has stock in Astra Zeneca.
Jaya Goyal	No disclosure on file
Matthew Klein	Matthew Klein has received personal compensation for serving as an employee of PTC Therapeutics. Matthew Klein has stock in PTC Therapeutics. Matthew Klein has received publishing royalties from a publication relating to health care.
Parul Houston	No disclosure on file
Philippe Picaut	No disclosure on file
Bing Zhu, MD	No disclosure on file
Jing Marantz	No disclosure on file
Celica Ysrraelit	Celica Ysrraelit has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Celica Ysrraelit has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Merck, . Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. Celica Ysrraelit has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bayer. Celica Ysrraelit has received research support from Novartis. The institution of Celica Ysrraelit has received research support from ROCHE. The institution of Celica Ysrraelit has received research support from Roche.
Muhammad F. Bilal, MD, FAAN	Dr. Bilal has nothing to disclose.
Cynthia Carrillo Infante, MD, PhD	No disclosure on file
Nolan Campbell	Nolan Campbell has received personal compensation for serving as an employee of Biogen. Nolan Campbell has stock in Biogen.
Nicholas J. Everage	No disclosure on file
Pei-Ran Ho	No disclosure on file
Ahmed Enayetallah, PhD, MBBCh	Dr. Enayetallah has received personal compensation for serving as an employee of Alexion. Dr. Enayetallah has received stock or an ownership interest from Alexion. Dr. Enayetallah has received stock or an ownership interest from AstraZeneca.
In Hye Jeong, MD	No disclosure on file
Anupam Pathak, PhD	No disclosure on file
Gerry Rowse	No disclosure on file
Robert Hendricks	No disclosure on file
Stephen Wanaski, PhD	Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has stock in Paragon Biosciences. Dr. Wanaski has stock in Emalex Biosciences.
Alexander Niyazov	No disclosure on file
Adama Ibrahim	No disclosure on file
Greg Mytyk	No disclosure on file
Feride H. Frech, PhD	Dr. Frech has received personal compensation for serving as an employee of Eisai Inc.